Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060255 | 0.00000 | 9.08743 | 9 | 28 | 5486 | regulation of macromolecule metabolic process |
| GO:0044260 | 0.00000 | 10.09023 | 12 | 31 | 7099 | cellular macromolecule metabolic process |
| GO:0031323 | 0.00000 | 8.12914 | 9 | 27 | 5401 | regulation of cellular metabolic process |
| GO:0019222 | 0.00000 | 8.15048 | 10 | 28 | 5953 | regulation of metabolic process |
| GO:0051171 | 0.00000 | 7.72030 | 8 | 26 | 5104 | regulation of nitrogen compound metabolic process |
| GO:0043170 | 0.00000 | 9.28161 | 14 | 32 | 8488 | macromolecule metabolic process |
| GO:0080090 | 0.00000 | 7.44766 | 9 | 26 | 5248 | regulation of primary metabolic process |
| GO:0071704 | 0.00000 | 11.24754 | 16 | 34 | 10008 | organic substance metabolic process |
| GO:0044237 | 0.00000 | 9.77247 | 15 | 33 | 9374 | cellular metabolic process |
| GO:0010942 | 0.00000 | 13.39441 | 1 | 11 | 695 | positive regulation of cell death |
| GO:0031324 | 0.00000 | 7.67869 | 4 | 18 | 2449 | negative regulation of cellular metabolic process |
| GO:0008152 | 0.00000 | 10.34623 | 17 | 34 | 10485 | metabolic process |
| GO:0048519 | 0.00000 | 6.55999 | 9 | 25 | 5278 | negative regulation of biological process |
| GO:0043618 | 0.00000 | 76.17260 | 0 | 5 | 51 | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0051172 | 0.00000 | 7.51270 | 4 | 17 | 2271 | negative regulation of nitrogen compound metabolic process |
| GO:0006357 | 0.00000 | 7.79694 | 3 | 16 | 1993 | regulation of transcription by RNA polymerase II |
| GO:0043620 | 0.00000 | 68.68984 | 0 | 5 | 56 | regulation of DNA-templated transcription in response to stress |
| GO:1901216 | 0.00000 | 37.92434 | 0 | 6 | 120 | positive regulation of neuron death |
| GO:0044238 | 0.00000 | 7.79853 | 15 | 32 | 9443 | primary metabolic process |
| GO:0006366 | 0.00000 | 7.56213 | 3 | 16 | 2049 | transcription by RNA polymerase II |
| GO:0043065 | 0.00000 | 12.94786 | 1 | 10 | 632 | positive regulation of apoptotic process |
| GO:0043068 | 0.00000 | 12.84176 | 1 | 10 | 637 | positive regulation of programmed cell death |
| GO:0048523 | 0.00000 | 6.08468 | 8 | 23 | 4687 | negative regulation of cellular process |
| GO:0048731 | 0.00000 | 5.98951 | 8 | 23 | 4746 | system development |
| GO:0048518 | 0.00000 | 6.00355 | 10 | 26 | 6171 | positive regulation of biological process |
| GO:0009892 | 0.00000 | 6.48223 | 5 | 18 | 2843 | negative regulation of metabolic process |
| GO:1901214 | 0.00000 | 16.89778 | 1 | 8 | 368 | regulation of neuron death |
| GO:0065007 | 0.00000 | 10.67548 | 20 | 35 | 12135 | biological regulation |
| GO:0042127 | 0.00000 | 7.68394 | 3 | 14 | 1649 | regulation of cell proliferation |
| GO:0007275 | 0.00000 | 5.72735 | 9 | 24 | 5362 | multicellular organism development |
| GO:0009888 | 0.00000 | 7.13359 | 3 | 15 | 1956 | tissue development |
| GO:0043525 | 0.00000 | 47.29320 | 0 | 5 | 79 | positive regulation of neuron apoptotic process |
| GO:0010941 | 0.00000 | 7.50583 | 3 | 14 | 1685 | regulation of cell death |
| GO:0043523 | 0.00000 | 20.13368 | 0 | 7 | 264 | regulation of neuron apoptotic process |
| GO:0008283 | 0.00000 | 6.98409 | 3 | 15 | 1994 | cell proliferation |
| GO:0048522 | 0.00000 | 5.58111 | 9 | 24 | 5469 | positive regulation of cellular process |
| GO:0050789 | 0.00000 | 8.64801 | 19 | 34 | 11520 | regulation of biological process |
| GO:0070997 | 0.00000 | 15.29807 | 1 | 8 | 405 | neuron death |
| GO:0050794 | 0.00000 | 7.63845 | 18 | 33 | 10774 | regulation of cellular process |
| GO:0035914 | 0.00000 | 42.14859 | 0 | 5 | 88 | skeletal muscle cell differentiation |
| GO:0006807 | 0.00000 | 6.02117 | 15 | 30 | 8923 | nitrogen compound metabolic process |
| GO:0051402 | 0.00000 | 18.06925 | 0 | 7 | 293 | neuron apoptotic process |
| GO:0042981 | 0.00000 | 7.49693 | 2 | 13 | 1516 | regulation of apoptotic process |
| GO:0048513 | 0.00000 | 5.64907 | 6 | 19 | 3504 | animal organ development |
| GO:0043067 | 0.00000 | 7.38646 | 3 | 13 | 1537 | regulation of programmed cell death |
| GO:0042326 | 0.00000 | 13.65045 | 1 | 8 | 452 | negative regulation of phosphorylation |
| GO:0048661 | 0.00000 | 34.60996 | 0 | 5 | 106 | positive regulation of smooth muscle cell proliferation |
| GO:0000122 | 0.00000 | 9.41348 | 1 | 10 | 857 | negative regulation of transcription by RNA polymerase II |
| GO:0048856 | 0.00000 | 5.07953 | 10 | 24 | 5871 | anatomical structure development |
| GO:0010605 | 0.00000 | 5.83517 | 4 | 16 | 2584 | negative regulation of macromolecule metabolic process |
| GO:0034654 | 0.00000 | 5.43499 | 5 | 18 | 3310 | nucleobase-containing compound biosynthetic process |
| GO:0019219 | 0.00000 | 5.35519 | 5 | 18 | 3352 | regulation of nucleobase-containing compound metabolic process |
| GO:0045934 | 0.00000 | 7.27148 | 2 | 12 | 1395 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0018130 | 0.00000 | 5.31418 | 6 | 18 | 3374 | heterocycle biosynthetic process |
| GO:0019438 | 0.00000 | 5.29204 | 6 | 18 | 3386 | aromatic compound biosynthetic process |
| GO:0030154 | 0.00000 | 5.02197 | 7 | 20 | 4218 | cell differentiation |
| GO:0051246 | 0.00000 | 5.58211 | 4 | 16 | 2687 | regulation of protein metabolic process |
| GO:0051173 | 0.00000 | 5.35286 | 5 | 17 | 3061 | positive regulation of nitrogen compound metabolic process |
| GO:0031326 | 0.00000 | 5.14137 | 6 | 18 | 3470 | regulation of cellular biosynthetic process |
| GO:0048583 | 0.00000 | 4.99689 | 6 | 19 | 3883 | regulation of response to stimulus |
| GO:0008219 | 0.00000 | 6.00711 | 3 | 14 | 2065 | cell death |
| GO:0031327 | 0.00000 | 6.86867 | 2 | 12 | 1471 | negative regulation of cellular biosynthetic process |
| GO:0009893 | 0.00000 | 5.11349 | 6 | 18 | 3486 | positive regulation of metabolic process |
| GO:0010563 | 0.00000 | 11.21884 | 1 | 8 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00000 | 11.21884 | 1 | 8 | 546 | negative regulation of phosphate metabolic process |
| GO:0008284 | 0.00000 | 8.24547 | 2 | 10 | 972 | positive regulation of cell proliferation |
| GO:1901362 | 0.00000 | 5.07216 | 6 | 18 | 3510 | organic cyclic compound biosynthetic process |
| GO:0000188 | 0.00000 | 141.78367 | 0 | 3 | 17 | inactivation of MAPK activity |
| GO:0045944 | 0.00000 | 7.36251 | 2 | 11 | 1226 | positive regulation of transcription by RNA polymerase II |
| GO:0009966 | 0.00000 | 5.36982 | 5 | 16 | 2780 | regulation of signal transduction |
| GO:0006355 | 0.00000 | 5.36101 | 5 | 16 | 2784 | regulation of transcription, DNA-templated |
| GO:0009889 | 0.00000 | 5.01793 | 6 | 18 | 3542 | regulation of biosynthetic process |
| GO:1903506 | 0.00000 | 5.34346 | 5 | 16 | 2792 | regulation of nucleic acid-templated transcription |
| GO:0009890 | 0.00000 | 6.68260 | 2 | 12 | 1509 | negative regulation of biosynthetic process |
| GO:2001141 | 0.00000 | 5.32385 | 5 | 16 | 2801 | regulation of RNA biosynthetic process |
| GO:0032502 | 0.00000 | 4.65778 | 10 | 24 | 6258 | developmental process |
| GO:0065009 | 0.00000 | 5.48600 | 4 | 15 | 2477 | regulation of molecular function |
| GO:0031325 | 0.00000 | 5.08190 | 5 | 17 | 3201 | positive regulation of cellular metabolic process |
| GO:0010604 | 0.00000 | 5.06161 | 5 | 17 | 3212 | positive regulation of macromolecule metabolic process |
| GO:0001933 | 0.00000 | 12.82254 | 1 | 7 | 408 | negative regulation of protein phosphorylation |
| GO:2000112 | 0.00000 | 5.04878 | 5 | 17 | 3219 | regulation of cellular macromolecule biosynthetic process |
| GO:0048869 | 0.00000 | 4.70998 | 7 | 20 | 4443 | cellular developmental process |
| GO:0032268 | 0.00000 | 5.44390 | 4 | 15 | 2494 | regulation of cellular protein metabolic process |
| GO:0051239 | 0.00000 | 4.99620 | 5 | 17 | 3248 | regulation of multicellular organismal process |
| GO:0006351 | 0.00000 | 5.16722 | 5 | 16 | 2875 | transcription, DNA-templated |
| GO:0006915 | 0.00000 | 5.97916 | 3 | 13 | 1867 | apoptotic process |
| GO:0097659 | 0.00000 | 5.15078 | 5 | 16 | 2883 | nucleic acid-templated transcription |
| GO:0032774 | 0.00000 | 5.12424 | 5 | 16 | 2896 | RNA biosynthetic process |
| GO:0010648 | 0.00001 | 6.88251 | 2 | 11 | 1306 | negative regulation of cell communication |
| GO:0023057 | 0.00001 | 6.86006 | 2 | 11 | 1310 | negative regulation of signaling |
| GO:0012501 | 0.00001 | 5.83854 | 3 | 13 | 1908 | programmed cell death |
| GO:0010556 | 0.00001 | 4.88516 | 5 | 17 | 3311 | regulation of macromolecule biosynthetic process |
| GO:0048660 | 0.00001 | 22.06943 | 0 | 5 | 163 | regulation of smooth muscle cell proliferation |
| GO:0070373 | 0.00001 | 38.27838 | 0 | 4 | 75 | negative regulation of ERK1 and ERK2 cascade |
| GO:0071276 | 0.00001 | 99.22286 | 0 | 3 | 23 | cellular response to cadmium ion |
| GO:0051254 | 0.00001 | 6.11581 | 3 | 12 | 1638 | positive regulation of RNA metabolic process |
| GO:0007049 | 0.00001 | 6.11177 | 3 | 12 | 1639 | cell cycle |
| GO:0048659 | 0.00001 | 21.38780 | 0 | 5 | 168 | smooth muscle cell proliferation |
| GO:0034263 | 0.00001 | 1287.27778 | 0 | 2 | 3 | positive regulation of autophagy in response to ER overload |
| GO:0043409 | 0.00001 | 20.99854 | 0 | 5 | 171 | negative regulation of MAPK cascade |
| GO:2000113 | 0.00001 | 6.49350 | 2 | 11 | 1379 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0051252 | 0.00001 | 4.82906 | 5 | 16 | 3049 | regulation of RNA metabolic process |
| GO:0090304 | 0.00001 | 4.44199 | 7 | 19 | 4277 | nucleic acid metabolic process |
| GO:0050896 | 0.00001 | 4.63563 | 16 | 29 | 9531 | response to stimulus |
| GO:0010558 | 0.00001 | 6.32135 | 2 | 11 | 1414 | negative regulation of macromolecule biosynthetic process |
| GO:1901360 | 0.00001 | 4.28316 | 9 | 21 | 5208 | organic cyclic compound metabolic process |
| GO:0050793 | 0.00001 | 4.93252 | 4 | 15 | 2721 | regulation of developmental process |
| GO:0009968 | 0.00001 | 6.74647 | 2 | 10 | 1175 | negative regulation of signal transduction |
| GO:0045892 | 0.00001 | 6.73430 | 2 | 10 | 1177 | negative regulation of transcription, DNA-templated |
| GO:1903507 | 0.00001 | 6.71008 | 2 | 10 | 1181 | negative regulation of nucleic acid-templated transcription |
| GO:1902679 | 0.00001 | 6.70405 | 2 | 10 | 1182 | negative regulation of RNA biosynthetic process |
| GO:0033554 | 0.00001 | 5.64627 | 3 | 12 | 1763 | cellular response to stress |
| GO:0044271 | 0.00002 | 4.34649 | 7 | 18 | 3993 | cellular nitrogen compound biosynthetic process |
| GO:0007519 | 0.00002 | 18.13447 | 0 | 5 | 197 | skeletal muscle tissue development |
| GO:1902110 | 0.00002 | 68.40296 | 0 | 3 | 32 | positive regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:0060538 | 0.00002 | 17.31569 | 0 | 5 | 206 | skeletal muscle organ development |
| GO:0006950 | 0.00002 | 4.36803 | 6 | 17 | 3640 | response to stress |
| GO:0045935 | 0.00002 | 5.41148 | 3 | 12 | 1833 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0042325 | 0.00002 | 5.79525 | 3 | 11 | 1533 | regulation of phosphorylation |
| GO:1902686 | 0.00002 | 63.98433 | 0 | 3 | 34 | mitochondrial outer membrane permeabilization involved in programmed cell death |
| GO:0045893 | 0.00002 | 5.78305 | 3 | 11 | 1536 | positive regulation of transcription, DNA-templated |
| GO:1903508 | 0.00002 | 5.76685 | 3 | 11 | 1540 | positive regulation of nucleic acid-templated transcription |
| GO:1902680 | 0.00002 | 5.76282 | 3 | 11 | 1541 | positive regulation of RNA biosynthetic process |
| GO:2000026 | 0.00002 | 5.03018 | 4 | 13 | 2184 | regulation of multicellular organismal development |
| GO:0046686 | 0.00003 | 61.98214 | 0 | 3 | 35 | response to cadmium ion |
| GO:0032269 | 0.00003 | 6.92437 | 2 | 9 | 1003 | negative regulation of cellular protein metabolic process |
| GO:0051253 | 0.00003 | 6.21610 | 2 | 10 | 1269 | negative regulation of RNA metabolic process |
| GO:0044092 | 0.00003 | 6.90260 | 2 | 9 | 1006 | negative regulation of molecular function |
| GO:0003002 | 0.00003 | 11.65106 | 1 | 6 | 373 | regionalization |
| GO:0048585 | 0.00003 | 5.62483 | 3 | 11 | 1576 | negative regulation of response to stimulus |
| GO:0035794 | 0.00003 | 58.33109 | 0 | 3 | 37 | positive regulation of mitochondrial membrane permeability |
| GO:0010646 | 0.00003 | 4.34568 | 5 | 16 | 3338 | regulation of cell communication |
| GO:0031400 | 0.00003 | 9.16807 | 1 | 7 | 564 | negative regulation of protein modification process |
| GO:0008637 | 0.00003 | 25.36009 | 0 | 4 | 111 | apoptotic mitochondrial changes |
| GO:0045595 | 0.00003 | 5.17619 | 3 | 12 | 1909 | regulation of cell differentiation |
| GO:0023051 | 0.00003 | 4.31231 | 6 | 16 | 3360 | regulation of signaling |
| GO:0008630 | 0.00003 | 25.12418 | 0 | 4 | 112 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0035556 | 0.00003 | 4.62754 | 4 | 14 | 2608 | intracellular signal transduction |
| GO:1902108 | 0.00004 | 55.08571 | 0 | 3 | 39 | regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:1905710 | 0.00004 | 55.08571 | 0 | 3 | 39 | positive regulation of membrane permeability |
| GO:0009952 | 0.00004 | 15.38348 | 0 | 5 | 231 | anterior/posterior pattern specification |
| GO:0032501 | 0.00004 | 3.95079 | 13 | 26 | 8233 | multicellular organismal process |
| GO:0033002 | 0.00004 | 15.17997 | 0 | 5 | 234 | muscle cell proliferation |
| GO:0034976 | 0.00004 | 14.98171 | 0 | 5 | 237 | response to endoplasmic reticulum stress |
| GO:0051248 | 0.00004 | 6.46752 | 2 | 9 | 1070 | negative regulation of protein metabolic process |
| GO:0010468 | 0.00005 | 4.07163 | 6 | 17 | 3860 | regulation of gene expression |
| GO:0097190 | 0.00005 | 8.52400 | 1 | 7 | 605 | apoptotic signaling pathway |
| GO:0051716 | 0.00005 | 3.80095 | 13 | 25 | 7810 | cellular response to stimulus |
| GO:0002761 | 0.00005 | 22.41225 | 0 | 4 | 125 | regulation of myeloid leukocyte differentiation |
| GO:2001233 | 0.00005 | 10.46140 | 1 | 6 | 414 | regulation of apoptotic signaling pathway |
| GO:0019220 | 0.00006 | 5.20856 | 3 | 11 | 1692 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00006 | 5.20522 | 3 | 11 | 1693 | regulation of phosphorus metabolic process |
| GO:0006139 | 0.00006 | 3.83354 | 8 | 19 | 4813 | nucleobase-containing compound metabolic process |
| GO:0051101 | 0.00006 | 21.69129 | 0 | 4 | 129 | regulation of DNA binding |
| GO:1902531 | 0.00006 | 5.14906 | 3 | 11 | 1710 | regulation of intracellular signal transduction |
| GO:0001932 | 0.00007 | 5.55408 | 2 | 10 | 1410 | regulation of protein phosphorylation |
| GO:0019538 | 0.00007 | 3.72485 | 9 | 20 | 5344 | protein metabolic process |
| GO:0009987 | 0.00008 | 8.45373 | 26 | 36 | 15803 | cellular process |
| GO:0034645 | 0.00008 | 3.87419 | 7 | 17 | 4022 | cellular macromolecule biosynthetic process |
| GO:0031399 | 0.00008 | 4.99022 | 3 | 11 | 1760 | regulation of protein modification process |
| GO:0044249 | 0.00008 | 3.71071 | 8 | 19 | 4938 | cellular biosynthetic process |
| GO:0046483 | 0.00008 | 3.70880 | 8 | 19 | 4940 | heterocycle metabolic process |
| GO:0032879 | 0.00009 | 4.20823 | 5 | 14 | 2835 | regulation of localization |
| GO:0035239 | 0.00009 | 6.62207 | 1 | 8 | 905 | tube morphogenesis |
| GO:0043392 | 0.00009 | 39.63771 | 0 | 3 | 53 | negative regulation of DNA binding |
| GO:0046902 | 0.00009 | 39.63771 | 0 | 3 | 53 | regulation of mitochondrial membrane permeability |
| GO:1904705 | 0.00009 | 39.63771 | 0 | 3 | 53 | regulation of vascular smooth muscle cell proliferation |
| GO:1990874 | 0.00009 | 39.63771 | 0 | 3 | 53 | vascular smooth muscle cell proliferation |
| GO:0045657 | 0.00009 | 183.84921 | 0 | 2 | 9 | positive regulation of monocyte differentiation |
| GO:0010557 | 0.00010 | 4.87248 | 3 | 11 | 1799 | positive regulation of macromolecule biosynthetic process |
| GO:0007166 | 0.00010 | 4.33082 | 4 | 13 | 2497 | cell surface receptor signaling pathway |
| GO:0006725 | 0.00010 | 3.64090 | 8 | 19 | 5012 | cellular aromatic compound metabolic process |
| GO:0007389 | 0.00010 | 9.21672 | 1 | 6 | 468 | pattern specification process |
| GO:0009059 | 0.00011 | 3.76121 | 7 | 17 | 4121 | macromolecule biosynthetic process |
| GO:0006468 | 0.00011 | 4.82565 | 3 | 11 | 1815 | protein phosphorylation |
| GO:0044267 | 0.00011 | 3.68247 | 7 | 18 | 4569 | cellular protein metabolic process |
| GO:0097193 | 0.00011 | 12.08162 | 0 | 5 | 292 | intrinsic apoptotic signaling pathway |
| GO:1901576 | 0.00011 | 3.62330 | 8 | 19 | 5031 | organic substance biosynthetic process |
| GO:0016310 | 0.00011 | 4.50354 | 4 | 12 | 2166 | phosphorylation |
| GO:0071248 | 0.00012 | 18.05647 | 0 | 4 | 154 | cellular response to metal ion |
| GO:0007165 | 0.00012 | 3.52985 | 10 | 21 | 6028 | signal transduction |
| GO:0061061 | 0.00012 | 7.31366 | 1 | 7 | 701 | muscle structure development |
| GO:0051726 | 0.00013 | 6.25836 | 2 | 8 | 955 | regulation of cell cycle |
| GO:0001836 | 0.00013 | 34.75940 | 0 | 3 | 60 | release of cytochrome c from mitochondria |
| GO:0016070 | 0.00013 | 3.77269 | 6 | 16 | 3761 | RNA metabolic process |
| GO:0070372 | 0.00014 | 11.51263 | 1 | 5 | 306 | regulation of ERK1 and ERK2 cascade |
| GO:0009058 | 0.00014 | 3.53819 | 8 | 19 | 5125 | biosynthetic process |
| GO:0032464 | 0.00014 | 142.98148 | 0 | 2 | 11 | positive regulation of protein homooligomerization |
| GO:1990440 | 0.00014 | 142.98148 | 0 | 2 | 11 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| GO:0001568 | 0.00015 | 7.12305 | 1 | 7 | 719 | blood vessel development |
| GO:0007154 | 0.00015 | 3.43356 | 11 | 22 | 6648 | cell communication |
| GO:0002763 | 0.00016 | 32.47447 | 0 | 3 | 64 | positive regulation of myeloid leukocyte differentiation |
| GO:0071479 | 0.00016 | 32.47447 | 0 | 3 | 64 | cellular response to ionizing radiation |
| GO:0031328 | 0.00016 | 4.58226 | 3 | 11 | 1903 | positive regulation of cellular biosynthetic process |
| GO:0090559 | 0.00016 | 31.94931 | 0 | 3 | 65 | regulation of membrane permeability |
| GO:0043408 | 0.00017 | 6.94185 | 1 | 7 | 737 | regulation of MAPK cascade |
| GO:0070371 | 0.00017 | 10.88908 | 1 | 5 | 323 | ERK1 and ERK2 cascade |
| GO:2001244 | 0.00019 | 30.47077 | 0 | 3 | 68 | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0001944 | 0.00019 | 6.79753 | 1 | 7 | 752 | vasculature development |
| GO:0043407 | 0.00020 | 30.00779 | 0 | 3 | 69 | negative regulation of MAP kinase activity |
| GO:0048146 | 0.00020 | 30.00779 | 0 | 3 | 69 | positive regulation of fibroblast proliferation |
| GO:1901564 | 0.00020 | 3.37186 | 10 | 21 | 6234 | organonitrogen compound metabolic process |
| GO:0009891 | 0.00020 | 4.47895 | 3 | 11 | 1943 | positive regulation of biosynthetic process |
| GO:1902532 | 0.00020 | 8.15175 | 1 | 6 | 527 | negative regulation of intracellular signal transduction |
| GO:0006983 | 0.00020 | 116.97475 | 0 | 2 | 13 | ER overload response |
| GO:0072358 | 0.00021 | 6.67708 | 1 | 7 | 765 | cardiovascular system development |
| GO:0009628 | 0.00022 | 5.77952 | 2 | 8 | 1030 | response to abiotic stimulus |
| GO:2001235 | 0.00022 | 15.11206 | 0 | 4 | 183 | positive regulation of apoptotic signaling pathway |
| GO:0010628 | 0.00023 | 4.38470 | 3 | 11 | 1981 | positive regulation of gene expression |
| GO:0035970 | 0.00023 | 107.22222 | 0 | 2 | 14 | peptidyl-threonine dephosphorylation |
| GO:0000165 | 0.00026 | 6.43117 | 1 | 7 | 793 | MAPK cascade |
| GO:0048699 | 0.00027 | 4.62223 | 3 | 10 | 1672 | generation of neurons |
| GO:0071277 | 0.00027 | 26.75444 | 0 | 3 | 77 | cellular response to calcium ion |
| GO:0007178 | 0.00028 | 9.82266 | 1 | 5 | 357 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0006469 | 0.00028 | 14.23034 | 0 | 4 | 194 | negative regulation of protein kinase activity |
| GO:0023014 | 0.00030 | 6.29024 | 1 | 7 | 810 | signal transduction by protein phosphorylation |
| GO:0042448 | 0.00031 | 91.89683 | 0 | 2 | 16 | progesterone metabolic process |
| GO:0045655 | 0.00031 | 91.89683 | 0 | 2 | 16 | regulation of monocyte differentiation |
| GO:0035295 | 0.00039 | 5.28019 | 2 | 8 | 1122 | tube development |
| GO:0009913 | 0.00040 | 12.92598 | 0 | 4 | 213 | epidermal cell differentiation |
| GO:0033673 | 0.00041 | 12.86387 | 0 | 4 | 214 | negative regulation of kinase activity |
| GO:0045637 | 0.00041 | 12.80234 | 0 | 4 | 215 | regulation of myeloid cell differentiation |
| GO:0002573 | 0.00042 | 12.74140 | 0 | 4 | 216 | myeloid leukocyte differentiation |
| GO:0034641 | 0.00042 | 3.19175 | 9 | 19 | 5547 | cellular nitrogen compound metabolic process |
| GO:0022008 | 0.00044 | 4.32369 | 3 | 10 | 1778 | neurogenesis |
| GO:0035994 | 0.00044 | 75.66993 | 0 | 2 | 19 | response to muscle stretch |
| GO:0009314 | 0.00044 | 8.85082 | 1 | 5 | 395 | response to radiation |
| GO:0023052 | 0.00044 | 3.12949 | 11 | 21 | 6579 | signaling |
| GO:0010629 | 0.00045 | 4.31049 | 3 | 10 | 1783 | negative regulation of gene expression |
| GO:0009991 | 0.00047 | 8.71442 | 1 | 5 | 401 | response to extracellular stimulus |
| GO:0031668 | 0.00047 | 12.33038 | 0 | 4 | 223 | cellular response to extracellular stimulus |
| GO:1901028 | 0.00049 | 71.46296 | 0 | 2 | 20 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GO:0071241 | 0.00049 | 12.21773 | 0 | 4 | 225 | cellular response to inorganic substance |
| GO:1903706 | 0.00050 | 8.58209 | 1 | 5 | 407 | regulation of hemopoiesis |
| GO:0007167 | 0.00053 | 5.69989 | 1 | 7 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0030182 | 0.00055 | 4.53229 | 2 | 9 | 1494 | neuron differentiation |
| GO:0007006 | 0.00055 | 20.82135 | 0 | 3 | 98 | mitochondrial membrane organization |
| GO:0045639 | 0.00057 | 20.60357 | 0 | 3 | 99 | positive regulation of myeloid cell differentiation |
| GO:0032462 | 0.00059 | 64.31111 | 0 | 2 | 22 | regulation of protein homooligomerization |
| GO:0070242 | 0.00059 | 64.31111 | 0 | 2 | 22 | thymocyte apoptotic process |
| GO:0009896 | 0.00059 | 8.26793 | 1 | 5 | 422 | positive regulation of catabolic process |
| GO:0007517 | 0.00061 | 8.22774 | 1 | 5 | 424 | muscle organ development |
| GO:0032461 | 0.00065 | 61.24603 | 0 | 2 | 23 | positive regulation of protein oligomerization |
| GO:0031334 | 0.00068 | 11.14730 | 0 | 4 | 246 | positive regulation of protein complex assembly |
| GO:0051348 | 0.00068 | 11.14730 | 0 | 4 | 246 | negative regulation of transferase activity |
| GO:0006464 | 0.00071 | 3.34717 | 6 | 14 | 3453 | cellular protein modification process |
| GO:0036211 | 0.00071 | 3.34717 | 6 | 14 | 3453 | protein modification process |
| GO:0048145 | 0.00071 | 19.01209 | 0 | 3 | 107 | regulation of fibroblast proliferation |
| GO:0010467 | 0.00074 | 3.10090 | 8 | 17 | 4814 | gene expression |
| GO:0048144 | 0.00075 | 18.65175 | 0 | 3 | 109 | fibroblast proliferation |
| GO:0008285 | 0.00077 | 6.24917 | 1 | 6 | 681 | negative regulation of cell proliferation |
| GO:0014706 | 0.00079 | 7.75594 | 1 | 5 | 449 | striated muscle tissue development |
| GO:0010033 | 0.00079 | 3.42159 | 5 | 13 | 3070 | response to organic substance |
| GO:0071901 | 0.00079 | 18.30476 | 0 | 3 | 111 | negative regulation of protein serine/threonine kinase activity |
| GO:0072012 | 0.00083 | 53.58333 | 0 | 2 | 26 | glomerulus vasculature development |
| GO:0051240 | 0.00083 | 3.95537 | 3 | 10 | 1929 | positive regulation of multicellular organismal process |
| GO:1901700 | 0.00086 | 4.24112 | 3 | 9 | 1589 | response to oxygen-containing compound |
| GO:0048870 | 0.00088 | 4.22390 | 3 | 9 | 1595 | cell motility |
| GO:0051674 | 0.00088 | 4.22390 | 3 | 9 | 1595 | localization of cell |
| GO:0036003 | 0.00089 | 51.43778 | 0 | 2 | 27 | positive regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0061437 | 0.00089 | 51.43778 | 0 | 2 | 27 | renal system vasculature development |
| GO:0061440 | 0.00089 | 51.43778 | 0 | 2 | 27 | kidney vasculature development |
| GO:0048534 | 0.00089 | 5.19636 | 2 | 7 | 972 | hematopoietic or lymphoid organ development |
| GO:0048732 | 0.00094 | 7.44786 | 1 | 5 | 467 | gland development |
| GO:0007399 | 0.00095 | 3.65824 | 4 | 11 | 2333 | nervous system development |
| GO:0010038 | 0.00096 | 10.16959 | 0 | 4 | 269 | response to metal ion |
| GO:0035335 | 0.00096 | 49.45726 | 0 | 2 | 28 | peptidyl-tyrosine dephosphorylation |
| GO:0090200 | 0.00096 | 49.45726 | 0 | 2 | 28 | positive regulation of release of cytochrome c from mitochondria |
| GO:0060537 | 0.00098 | 7.36649 | 1 | 5 | 472 | muscle tissue development |
| GO:0010508 | 0.00100 | 16.89011 | 0 | 3 | 120 | positive regulation of autophagy |
| GO:0001889 | 0.00102 | 16.74625 | 0 | 3 | 121 | liver development |
| GO:0030224 | 0.00103 | 47.62346 | 0 | 2 | 29 | monocyte differentiation |
| GO:0097345 | 0.00103 | 47.62346 | 0 | 2 | 29 | mitochondrial outer membrane permeabilization |
| GO:1903131 | 0.00103 | 47.62346 | 0 | 2 | 29 | mononuclear cell differentiation |
| GO:0051247 | 0.00107 | 4.10150 | 3 | 9 | 1639 | positive regulation of protein metabolic process |
| GO:0051179 | 0.00108 | 2.90693 | 10 | 19 | 5950 | localization |
| GO:0061008 | 0.00110 | 16.32893 | 0 | 3 | 124 | hepaticobiliary system development |
| GO:0010212 | 0.00112 | 16.19438 | 0 | 3 | 125 | response to ionizing radiation |
| GO:0001822 | 0.00112 | 9.72393 | 0 | 4 | 281 | kidney development |
| GO:0051592 | 0.00117 | 15.93180 | 0 | 3 | 127 | response to calcium ion |
| GO:0071496 | 0.00118 | 9.58384 | 0 | 4 | 285 | cellular response to external stimulus |
| GO:0006974 | 0.00119 | 5.73178 | 1 | 6 | 740 | cellular response to DNA damage stimulus |
| GO:0007346 | 0.00119 | 7.04297 | 1 | 5 | 493 | regulation of mitotic cell cycle |
| GO:0043412 | 0.00120 | 3.15064 | 6 | 14 | 3634 | macromolecule modification |
| GO:0002520 | 0.00125 | 4.88894 | 2 | 7 | 1030 | immune system development |
| GO:0007611 | 0.00129 | 9.34804 | 0 | 4 | 292 | learning or memory |
| GO:1902105 | 0.00133 | 9.28276 | 0 | 4 | 294 | regulation of leukocyte differentiation |
| GO:0043405 | 0.00134 | 9.25045 | 0 | 4 | 295 | regulation of MAP kinase activity |
| GO:0042221 | 0.00139 | 3.01494 | 7 | 15 | 4136 | response to chemical |
| GO:0006984 | 0.00142 | 40.17361 | 0 | 2 | 34 | ER-nucleus signaling pathway |
| GO:0010821 | 0.00143 | 14.84791 | 0 | 3 | 136 | regulation of mitochondrion organization |
| GO:0072001 | 0.00146 | 9.03040 | 0 | 4 | 302 | renal system development |
| GO:0043304 | 0.00150 | 38.95455 | 0 | 2 | 35 | regulation of mast cell degranulation |
| GO:1902895 | 0.00150 | 38.95455 | 0 | 2 | 35 | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:1904707 | 0.00150 | 38.95455 | 0 | 2 | 35 | positive regulation of vascular smooth muscle cell proliferation |
| GO:0033006 | 0.00159 | 37.80719 | 0 | 2 | 36 | regulation of mast cell activation involved in immune response |
| GO:0044324 | 0.00164 | Inf | 0 | 1 | 1 | regulation of transcription involved in anterior/posterior axis specification |
| GO:0061105 | 0.00164 | Inf | 0 | 1 | 1 | regulation of stomach neuroendocrine cell differentiation |
| GO:0061106 | 0.00164 | Inf | 0 | 1 | 1 | negative regulation of stomach neuroendocrine cell differentiation |
| GO:0071228 | 0.00164 | Inf | 0 | 1 | 1 | cellular response to tumor cell |
| GO:0071324 | 0.00164 | Inf | 0 | 1 | 1 | cellular response to disaccharide stimulus |
| GO:0071329 | 0.00164 | Inf | 0 | 1 | 1 | cellular response to sucrose stimulus |
| GO:0072303 | 0.00164 | Inf | 0 | 1 | 1 | positive regulation of glomerular metanephric mesangial cell proliferation |
| GO:0110077 | 0.00164 | Inf | 0 | 1 | 1 | vesicle-mediated intercellular transport |
| GO:1905933 | 0.00164 | Inf | 0 | 1 | 1 | regulation of cell fate determination |
| GO:1905934 | 0.00164 | Inf | 0 | 1 | 1 | negative regulation of cell fate determination |
| GO:0071216 | 0.00167 | 8.70474 | 1 | 4 | 313 | cellular response to biotic stimulus |
| GO:0031175 | 0.00167 | 4.63701 | 2 | 7 | 1083 | neuron projection development |
| GO:0007616 | 0.00177 | 35.70370 | 0 | 2 | 38 | long-term memory |
| GO:0072210 | 0.00177 | 35.70370 | 0 | 2 | 38 | metanephric nephron development |
| GO:0009605 | 0.00177 | 3.36274 | 4 | 11 | 2515 | response to external stimulus |
| GO:0006796 | 0.00184 | 3.19980 | 5 | 12 | 2933 | phosphate-containing compound metabolic process |
| GO:0008207 | 0.00186 | 34.73724 | 0 | 2 | 39 | C21-steroid hormone metabolic process |
| GO:0044093 | 0.00188 | 4.08182 | 2 | 8 | 1429 | positive regulation of molecular function |
| GO:0050890 | 0.00194 | 8.34856 | 1 | 4 | 326 | cognition |
| GO:0006793 | 0.00196 | 3.17243 | 5 | 12 | 2955 | phosphorus metabolic process |
| GO:0008544 | 0.00200 | 8.27041 | 1 | 4 | 329 | epidermis development |
| GO:0071478 | 0.00204 | 13.06774 | 0 | 3 | 154 | cellular response to radiation |
| GO:0032459 | 0.00206 | 32.95299 | 0 | 2 | 41 | regulation of protein oligomerization |
| GO:1900744 | 0.00206 | 32.95299 | 0 | 2 | 41 | regulation of p38MAPK cascade |
| GO:0040011 | 0.00220 | 3.66715 | 3 | 9 | 1817 | locomotion |
| GO:0002521 | 0.00220 | 6.09565 | 1 | 5 | 567 | leukocyte differentiation |
| GO:0043433 | 0.00227 | 12.56506 | 0 | 3 | 160 | negative regulation of DNA-binding transcription factor activity |
| GO:0072359 | 0.00228 | 4.38017 | 2 | 7 | 1143 | circulatory system development |
| GO:0002682 | 0.00228 | 3.95122 | 2 | 8 | 1473 | regulation of immune system process |
| GO:0070887 | 0.00239 | 3.09036 | 5 | 12 | 3023 | cellular response to chemical stimulus |
| GO:0001655 | 0.00240 | 7.85346 | 1 | 4 | 346 | urogenital system development |
| GO:0048646 | 0.00244 | 4.32410 | 2 | 7 | 1157 | anatomical structure formation involved in morphogenesis |
| GO:1902893 | 0.00247 | 29.88243 | 0 | 2 | 45 | regulation of pri-miRNA transcription by RNA polymerase II |
| GO:0042594 | 0.00252 | 12.09939 | 0 | 3 | 166 | response to starvation |
| GO:0009967 | 0.00260 | 3.86381 | 2 | 8 | 1504 | positive regulation of signal transduction |
| GO:1902107 | 0.00261 | 11.95169 | 0 | 3 | 168 | positive regulation of leukocyte differentiation |
| GO:0060429 | 0.00262 | 4.26551 | 2 | 7 | 1172 | epithelium development |
| GO:0031331 | 0.00264 | 7.64907 | 1 | 4 | 355 | positive regulation of cellular catabolic process |
| GO:2001242 | 0.00265 | 11.87917 | 0 | 3 | 169 | regulation of intrinsic apoptotic signaling pathway |
| GO:0090199 | 0.00269 | 28.55185 | 0 | 2 | 47 | regulation of release of cytochrome c from mitochondria |
| GO:1902041 | 0.00269 | 28.55185 | 0 | 2 | 47 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0038066 | 0.00281 | 27.92995 | 0 | 2 | 48 | p38MAPK cascade |
| GO:0043303 | 0.00281 | 27.92995 | 0 | 2 | 48 | mast cell degranulation |
| GO:0051100 | 0.00283 | 11.59765 | 0 | 3 | 173 | negative regulation of binding |
| GO:0032270 | 0.00291 | 3.78793 | 3 | 8 | 1532 | positive regulation of cellular protein metabolic process |
| GO:0002279 | 0.00292 | 27.33452 | 0 | 2 | 49 | mast cell activation involved in immune response |
| GO:0002448 | 0.00292 | 27.33452 | 0 | 2 | 49 | mast cell mediated immunity |
| GO:0043300 | 0.00292 | 27.33452 | 0 | 2 | 49 | regulation of leukocyte degranulation |
| GO:0051094 | 0.00301 | 3.76675 | 3 | 8 | 1540 | positive regulation of developmental process |
| GO:0033003 | 0.00304 | 26.76389 | 0 | 2 | 50 | regulation of mast cell activation |
| GO:0043524 | 0.00307 | 11.26384 | 0 | 3 | 178 | negative regulation of neuron apoptotic process |
| GO:0031667 | 0.00309 | 7.31047 | 1 | 4 | 371 | response to nutrient levels |
| GO:0006839 | 0.00312 | 11.19935 | 0 | 3 | 179 | mitochondrial transport |
| GO:0070848 | 0.00313 | 5.60407 | 1 | 5 | 615 | response to growth factor |
| GO:0032355 | 0.00316 | 26.21655 | 0 | 2 | 51 | response to estradiol |
| GO:0051259 | 0.00317 | 5.58526 | 1 | 5 | 617 | protein complex oligomerization |
| GO:0006788 | 0.00327 | 626.24324 | 0 | 1 | 2 | heme oxidation |
| GO:0009744 | 0.00327 | 626.24324 | 0 | 1 | 2 | response to sucrose |
| GO:0032764 | 0.00327 | 626.24324 | 0 | 1 | 2 | negative regulation of mast cell cytokine production |
| GO:0034285 | 0.00327 | 626.24324 | 0 | 1 | 2 | response to disaccharide |
| GO:0035026 | 0.00327 | 626.24324 | 0 | 1 | 2 | leading edge cell differentiation |
| GO:0045168 | 0.00327 | 626.24324 | 0 | 1 | 2 | cell-cell signaling involved in cell fate commitment |
| GO:0045977 | 0.00327 | 626.24324 | 0 | 1 | 2 | positive regulation of mitotic cell cycle, embryonic |
| GO:0046331 | 0.00327 | 626.24324 | 0 | 1 | 2 | lateral inhibition |
| GO:0060598 | 0.00327 | 626.24324 | 0 | 1 | 2 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis |
| GO:0061102 | 0.00327 | 626.24324 | 0 | 1 | 2 | stomach neuroendocrine cell differentiation |
| GO:0071505 | 0.00327 | 626.24324 | 0 | 1 | 2 | response to mycophenolic acid |
| GO:0071506 | 0.00327 | 626.24324 | 0 | 1 | 2 | cellular response to mycophenolic acid |
| GO:0072071 | 0.00327 | 626.24324 | 0 | 1 | 2 | kidney interstitial fibroblast differentiation |
| GO:0072141 | 0.00327 | 626.24324 | 0 | 1 | 2 | renal interstitial fibroblast development |
| GO:0072301 | 0.00327 | 626.24324 | 0 | 1 | 2 | regulation of metanephric glomerular mesangial cell proliferation |
| GO:0098758 | 0.00327 | 626.24324 | 0 | 1 | 2 | response to interleukin-8 |
| GO:0098759 | 0.00327 | 626.24324 | 0 | 1 | 2 | cellular response to interleukin-8 |
| GO:1990408 | 0.00327 | 626.24324 | 0 | 1 | 2 | calcitonin gene-related peptide receptor signaling pathway |
| GO:2000226 | 0.00327 | 626.24324 | 0 | 1 | 2 | regulation of pancreatic A cell differentiation |
| GO:2000227 | 0.00327 | 626.24324 | 0 | 1 | 2 | negative regulation of pancreatic A cell differentiation |
| GO:0048514 | 0.00329 | 5.53878 | 1 | 5 | 622 | blood vessel morphogenesis |
| GO:0061614 | 0.00329 | 25.69111 | 0 | 2 | 52 | pri-miRNA transcription by RNA polymerase II |
| GO:0048666 | 0.00331 | 4.08068 | 2 | 7 | 1222 | neuron development |
| GO:0030855 | 0.00338 | 5.50212 | 1 | 5 | 626 | epithelial cell differentiation |
| GO:0051260 | 0.00346 | 7.07528 | 1 | 4 | 383 | protein homooligomerization |
| GO:0014009 | 0.00354 | 24.70085 | 0 | 2 | 54 | glial cell proliferation |
| GO:0045604 | 0.00354 | 24.70085 | 0 | 2 | 54 | regulation of epidermal cell differentiation |
| GO:0006914 | 0.00356 | 7.01879 | 1 | 4 | 386 | autophagy |
| GO:0061919 | 0.00356 | 7.01879 | 1 | 4 | 386 | process utilizing autophagic mechanism |
| GO:0030097 | 0.00358 | 4.56086 | 2 | 6 | 921 | hemopoiesis |
| GO:0043066 | 0.00358 | 4.56086 | 2 | 6 | 921 | negative regulation of apoptotic process |
| GO:0048538 | 0.00380 | 23.78395 | 0 | 2 | 56 | thymus development |
| GO:0031669 | 0.00391 | 10.31309 | 0 | 3 | 194 | cellular response to nutrient levels |
| GO:0043069 | 0.00393 | 4.46925 | 2 | 6 | 939 | negative regulation of programmed cell death |
| GO:2000145 | 0.00393 | 4.46925 | 2 | 6 | 939 | regulation of cell motility |
| GO:0006979 | 0.00404 | 6.76649 | 1 | 4 | 400 | response to oxidative stress |
| GO:0032835 | 0.00407 | 22.93254 | 0 | 2 | 58 | glomerulus development |
| GO:0070231 | 0.00407 | 22.93254 | 0 | 2 | 58 | T cell apoptotic process |
| GO:0030099 | 0.00407 | 6.74915 | 1 | 4 | 401 | myeloid cell differentiation |
| GO:0051098 | 0.00415 | 6.71473 | 1 | 4 | 403 | regulation of binding |
| GO:0045859 | 0.00428 | 5.19233 | 1 | 5 | 662 | regulation of protein kinase activity |
| GO:0050767 | 0.00429 | 4.38592 | 2 | 6 | 956 | regulation of neurogenesis |
| GO:0000302 | 0.00432 | 9.94545 | 0 | 3 | 201 | response to reactive oxygen species |
| GO:0048468 | 0.00437 | 3.09683 | 4 | 10 | 2406 | cell development |
| GO:0006928 | 0.00441 | 3.27634 | 3 | 9 | 2014 | movement of cell or subcellular component |
| GO:0042698 | 0.00449 | 21.76365 | 0 | 2 | 61 | ovulation cycle |
| GO:0001666 | 0.00450 | 9.79574 | 0 | 3 | 204 | response to hypoxia |
| GO:0014911 | 0.00464 | 21.40000 | 0 | 2 | 62 | positive regulation of smooth muscle cell migration |
| GO:0071310 | 0.00474 | 3.05834 | 4 | 10 | 2433 | cellular response to organic substance |
| GO:1903708 | 0.00475 | 9.60293 | 0 | 3 | 208 | positive regulation of hemopoiesis |
| GO:0070059 | 0.00479 | 21.04827 | 0 | 2 | 63 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| GO:0043086 | 0.00486 | 5.03447 | 1 | 5 | 682 | negative regulation of catalytic activity |
| GO:0021558 | 0.00490 | 313.10811 | 0 | 1 | 3 | trochlear nerve development |
| GO:0034395 | 0.00490 | 313.10811 | 0 | 1 | 3 | regulation of transcription from RNA polymerase II promoter in response to iron |
| GO:0052151 | 0.00490 | 313.10811 | 0 | 1 | 3 | positive regulation by symbiont of host apoptotic process |
| GO:0060086 | 0.00490 | 313.10811 | 0 | 1 | 3 | circadian temperature homeostasis |
| GO:0060139 | 0.00490 | 313.10811 | 0 | 1 | 3 | positive regulation of apoptotic process by virus |
| GO:0060154 | 0.00490 | 313.10811 | 0 | 1 | 3 | cellular process regulating host cell cycle in response to virus |
| GO:0060720 | 0.00490 | 313.10811 | 0 | 1 | 3 | spongiotrophoblast cell proliferation |
| GO:0060722 | 0.00490 | 313.10811 | 0 | 1 | 3 | cell proliferation involved in embryonic placenta development |
| GO:1900739 | 0.00490 | 313.10811 | 0 | 1 | 3 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway |
| GO:1900740 | 0.00490 | 313.10811 | 0 | 1 | 3 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway |
| GO:1902263 | 0.00490 | 313.10811 | 0 | 1 | 3 | apoptotic process involved in embryonic digit morphogenesis |
| GO:1903984 | 0.00490 | 313.10811 | 0 | 1 | 3 | positive regulation of TRAIL-activated apoptotic signaling pathway |
| GO:1905078 | 0.00490 | 313.10811 | 0 | 1 | 3 | positive regulation of interleukin-17 secretion |
| GO:1905457 | 0.00490 | 313.10811 | 0 | 1 | 3 | negative regulation of lymphoid progenitor cell differentiation |
| GO:1990442 | 0.00490 | 313.10811 | 0 | 1 | 3 | intrinsic apoptotic signaling pathway in response to nitrosative stress |
| GO:2000016 | 0.00490 | 313.10811 | 0 | 1 | 3 | negative regulation of determination of dorsal identity |
| GO:2000182 | 0.00490 | 313.10811 | 0 | 1 | 3 | regulation of progesterone biosynthetic process |
| GO:2000974 | 0.00490 | 313.10811 | 0 | 1 | 3 | negative regulation of pro-B cell differentiation |
| GO:0006816 | 0.00492 | 6.38860 | 1 | 4 | 423 | calcium ion transport |
| GO:0050673 | 0.00500 | 6.35769 | 1 | 4 | 425 | epithelial cell proliferation |
| GO:0071900 | 0.00509 | 6.32708 | 1 | 4 | 427 | regulation of protein serine/threonine kinase activity |
| GO:0002886 | 0.00509 | 20.37831 | 0 | 2 | 65 | regulation of myeloid leukocyte mediated immunity |
| GO:0030968 | 0.00509 | 20.37831 | 0 | 2 | 65 | endoplasmic reticulum unfolded protein response |
| GO:0008406 | 0.00514 | 9.32742 | 0 | 3 | 214 | gonad development |
| GO:0002274 | 0.00521 | 9.28302 | 0 | 3 | 215 | myeloid leukocyte activation |
| GO:0032922 | 0.00524 | 20.05903 | 0 | 2 | 66 | circadian regulation of gene expression |
| GO:0031329 | 0.00526 | 4.93676 | 1 | 5 | 695 | regulation of cellular catabolic process |
| GO:0048168 | 0.00540 | 19.74957 | 0 | 2 | 67 | regulation of neuronal synaptic plasticity |
| GO:0045137 | 0.00541 | 9.15229 | 0 | 3 | 218 | development of primary sexual characteristics |
| GO:1902533 | 0.00547 | 4.16160 | 2 | 6 | 1005 | positive regulation of intracellular signal transduction |
| GO:0051241 | 0.00556 | 3.69065 | 2 | 7 | 1343 | negative regulation of multicellular organismal process |
| GO:0043299 | 0.00571 | 19.15837 | 0 | 2 | 69 | leukocyte degranulation |
| GO:0045576 | 0.00571 | 19.15837 | 0 | 2 | 69 | mast cell activation |
| GO:0040012 | 0.00582 | 4.10573 | 2 | 6 | 1018 | regulation of locomotion |
| GO:0048608 | 0.00607 | 6.00846 | 1 | 4 | 449 | reproductive structure development |
| GO:0065003 | 0.00608 | 3.32380 | 3 | 8 | 1729 | protein-containing complex assembly |
| GO:0051270 | 0.00610 | 4.06372 | 2 | 6 | 1028 | regulation of cellular component movement |
| GO:0043254 | 0.00616 | 5.98105 | 1 | 4 | 451 | regulation of protein complex assembly |
| GO:0097191 | 0.00620 | 8.70265 | 0 | 3 | 229 | extrinsic apoptotic signaling pathway |
| GO:0043627 | 0.00621 | 18.33492 | 0 | 2 | 72 | response to estrogen |
| GO:0045786 | 0.00621 | 5.96744 | 1 | 4 | 452 | negative regulation of cell cycle |
| GO:0061458 | 0.00626 | 5.95388 | 1 | 4 | 453 | reproductive system development |
| GO:0036293 | 0.00628 | 8.66394 | 0 | 3 | 230 | response to decreased oxygen levels |
| GO:0045670 | 0.00638 | 18.07590 | 0 | 2 | 73 | regulation of osteoclast differentiation |
| GO:0043549 | 0.00638 | 4.70451 | 1 | 5 | 728 | regulation of kinase activity |
| GO:0045930 | 0.00650 | 8.54981 | 0 | 3 | 233 | negative regulation of mitotic cell cycle |
| GO:0001907 | 0.00653 | 208.72973 | 0 | 1 | 4 | killing by symbiont of host cells |
| GO:0006787 | 0.00653 | 208.72973 | 0 | 1 | 4 | porphyrin-containing compound catabolic process |
| GO:0021555 | 0.00653 | 208.72973 | 0 | 1 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0021557 | 0.00653 | 208.72973 | 0 | 1 | 4 | oculomotor nerve development |
| GO:0032763 | 0.00653 | 208.72973 | 0 | 1 | 4 | regulation of mast cell cytokine production |
| GO:0035910 | 0.00653 | 208.72973 | 0 | 1 | 4 | ascending aorta morphogenesis |
| GO:0036146 | 0.00653 | 208.72973 | 0 | 1 | 4 | cellular response to mycotoxin |
| GO:0042167 | 0.00653 | 208.72973 | 0 | 1 | 4 | heme catabolic process |
| GO:0044004 | 0.00653 | 208.72973 | 0 | 1 | 4 | disruption by symbiont of host cell |
| GO:0044533 | 0.00653 | 208.72973 | 0 | 1 | 4 | positive regulation of apoptotic process in other organism |
| GO:0045608 | 0.00653 | 208.72973 | 0 | 1 | 4 | negative regulation of inner ear auditory receptor cell differentiation |
| GO:0045632 | 0.00653 | 208.72973 | 0 | 1 | 4 | negative regulation of mechanoreceptor differentiation |
| GO:0046149 | 0.00653 | 208.72973 | 0 | 1 | 4 | pigment catabolic process |
| GO:0051365 | 0.00653 | 208.72973 | 0 | 1 | 4 | cellular response to potassium ion starvation |
| GO:0052042 | 0.00653 | 208.72973 | 0 | 1 | 4 | positive regulation by symbiont of host programmed cell death |
| GO:0052330 | 0.00653 | 208.72973 | 0 | 1 | 4 | positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction |
| GO:0052501 | 0.00653 | 208.72973 | 0 | 1 | 4 | positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction |
| GO:0071503 | 0.00653 | 208.72973 | 0 | 1 | 4 | response to heparin |
| GO:0071504 | 0.00653 | 208.72973 | 0 | 1 | 4 | cellular response to heparin |
| GO:0072223 | 0.00653 | 208.72973 | 0 | 1 | 4 | metanephric glomerular mesangium development |
| GO:0072262 | 0.00653 | 208.72973 | 0 | 1 | 4 | metanephric glomerular mesangial cell proliferation involved in metanephros development |
| GO:0072719 | 0.00653 | 208.72973 | 0 | 1 | 4 | cellular response to cisplatin |
| GO:0090214 | 0.00653 | 208.72973 | 0 | 1 | 4 | spongiotrophoblast layer developmental growth |
| GO:1903121 | 0.00653 | 208.72973 | 0 | 1 | 4 | regulation of TRAIL-activated apoptotic signaling pathway |
| GO:1990410 | 0.00653 | 208.72973 | 0 | 1 | 4 | adrenomedullin receptor signaling pathway |
| GO:2000978 | 0.00653 | 208.72973 | 0 | 1 | 4 | negative regulation of forebrain neuron differentiation |
| GO:2000981 | 0.00653 | 208.72973 | 0 | 1 | 4 | negative regulation of inner ear receptor cell differentiation |
| GO:0006919 | 0.00655 | 17.82407 | 0 | 2 | 74 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0010822 | 0.00655 | 17.82407 | 0 | 2 | 74 | positive regulation of mitochondrion organization |
| GO:0097327 | 0.00655 | 17.82407 | 0 | 2 | 74 | response to antineoplastic agent |
| GO:0007005 | 0.00655 | 5.87382 | 1 | 4 | 459 | mitochondrion organization |
| GO:0014070 | 0.00660 | 4.66455 | 1 | 5 | 734 | response to organic cyclic compound |
| GO:0060548 | 0.00672 | 3.97813 | 2 | 6 | 1049 | negative regulation of cell death |
| GO:0008625 | 0.00672 | 17.57915 | 0 | 2 | 75 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0032418 | 0.00672 | 17.57915 | 0 | 2 | 75 | lysosome localization |
| GO:0006470 | 0.00689 | 8.36608 | 0 | 3 | 238 | protein dephosphorylation |
| GO:0009719 | 0.00719 | 3.50628 | 2 | 7 | 1409 | response to endogenous stimulus |
| GO:0070838 | 0.00722 | 5.70739 | 1 | 4 | 472 | divalent metal ion transport |
| GO:0002683 | 0.00727 | 5.69497 | 1 | 4 | 473 | negative regulation of immune system process |
| GO:0072511 | 0.00738 | 5.67029 | 1 | 4 | 475 | divalent inorganic cation transport |
| GO:1901215 | 0.00738 | 8.15566 | 0 | 3 | 244 | negative regulation of neuron death |
| GO:0051960 | 0.00741 | 3.89208 | 2 | 6 | 1071 | regulation of nervous system development |
| GO:0002684 | 0.00744 | 3.88825 | 2 | 6 | 1072 | positive regulation of immune system process |
| GO:0022603 | 0.00758 | 3.87301 | 2 | 6 | 1076 | regulation of anatomical structure morphogenesis |
| GO:0045682 | 0.00761 | 16.44872 | 0 | 2 | 80 | regulation of epidermis development |
| GO:0010506 | 0.00763 | 8.05433 | 0 | 3 | 247 | regulation of autophagy |
| GO:0050790 | 0.00789 | 3.16813 | 3 | 8 | 1807 | regulation of catalytic activity |
| GO:0002703 | 0.00789 | 7.95547 | 0 | 3 | 250 | regulation of leukocyte mediated immunity |
| GO:0002718 | 0.00798 | 16.03611 | 0 | 2 | 82 | regulation of cytokine production involved in immune response |
| GO:0034620 | 0.00798 | 16.03611 | 0 | 2 | 82 | cellular response to unfolded protein |
| GO:0060284 | 0.00816 | 3.80951 | 2 | 6 | 1093 | regulation of cell development |
| GO:0001844 | 0.00816 | 156.54054 | 0 | 1 | 5 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway |
| GO:0002085 | 0.00816 | 156.54054 | 0 | 1 | 5 | inhibition of neuroepithelial cell differentiation |
| GO:0006701 | 0.00816 | 156.54054 | 0 | 1 | 5 | progesterone biosynthetic process |
| GO:0009794 | 0.00816 | 156.54054 | 0 | 1 | 5 | regulation of mitotic cell cycle, embryonic |
| GO:0033015 | 0.00816 | 156.54054 | 0 | 1 | 5 | tetrapyrrole catabolic process |
| GO:0035905 | 0.00816 | 156.54054 | 0 | 1 | 5 | ascending aorta development |
| GO:0045448 | 0.00816 | 156.54054 | 0 | 1 | 5 | mitotic cell cycle, embryonic |
| GO:0052150 | 0.00816 | 156.54054 | 0 | 1 | 5 | modulation by symbiont of host apoptotic process |
| GO:0060164 | 0.00816 | 156.54054 | 0 | 1 | 5 | regulation of timing of neuron differentiation |
| GO:0060750 | 0.00816 | 156.54054 | 0 | 1 | 5 | epithelial cell proliferation involved in mammary gland duct elongation |
| GO:0061476 | 0.00816 | 156.54054 | 0 | 1 | 5 | response to anticoagulant |
| GO:0072300 | 0.00816 | 156.54054 | 0 | 1 | 5 | positive regulation of metanephric glomerulus development |
| GO:0072718 | 0.00816 | 156.54054 | 0 | 1 | 5 | response to cisplatin |
| GO:1902949 | 0.00816 | 156.54054 | 0 | 1 | 5 | positive regulation of tau-protein kinase activity |
| GO:1990441 | 0.00816 | 156.54054 | 0 | 1 | 5 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| GO:0016477 | 0.00828 | 3.40780 | 2 | 7 | 1447 | cell migration |
| GO:0045597 | 0.00830 | 3.79486 | 2 | 6 | 1097 | positive regulation of cell differentiation |
| GO:0045664 | 0.00830 | 4.40219 | 1 | 5 | 776 | regulation of neuron differentiation |
| GO:0003151 | 0.00836 | 15.64363 | 0 | 2 | 84 | outflow tract morphogenesis |
| GO:0010035 | 0.00839 | 5.45724 | 1 | 4 | 493 | response to inorganic substance |
| GO:0006812 | 0.00844 | 3.78031 | 2 | 6 | 1101 | cation transport |
| GO:0002275 | 0.00855 | 15.45448 | 0 | 2 | 85 | myeloid cell activation involved in immune response |
| GO:0014910 | 0.00855 | 15.45448 | 0 | 2 | 85 | regulation of smooth muscle cell migration |
| GO:0002699 | 0.00869 | 7.67277 | 0 | 3 | 259 | positive regulation of immune effector process |
| GO:0022402 | 0.00870 | 3.75510 | 2 | 6 | 1108 | cell cycle process |
| GO:0002376 | 0.00895 | 2.76106 | 4 | 10 | 2664 | immune system process |
| GO:0003006 | 0.00898 | 4.31529 | 1 | 5 | 791 | developmental process involved in reproduction |
| GO:0010647 | 0.00916 | 3.08068 | 3 | 8 | 1854 | positive regulation of cell communication |
| GO:0023056 | 0.00933 | 3.06983 | 3 | 8 | 1860 | positive regulation of signaling |
| GO:0001656 | 0.00934 | 14.74138 | 0 | 2 | 89 | metanephros development |
| GO:0000278 | 0.00935 | 4.27028 | 1 | 5 | 799 | mitotic cell cycle |
| GO:0034599 | 0.00953 | 7.40927 | 0 | 3 | 268 | cellular response to oxidative stress |
| GO:0060395 | 0.00955 | 14.57323 | 0 | 2 | 90 | SMAD protein signal transduction |
| GO:0072655 | 0.00955 | 14.57323 | 0 | 2 | 90 | establishment of protein localization to mitochondrion |
| GO:0001525 | 0.00961 | 5.23818 | 1 | 4 | 513 | angiogenesis |
| GO:0001938 | 0.00975 | 14.40886 | 0 | 2 | 91 | positive regulation of endothelial cell proliferation |
| GO:0010046 | 0.00978 | 125.22703 | 0 | 1 | 6 | response to mycotoxin |
| GO:0010496 | 0.00978 | 125.22703 | 0 | 1 | 6 | intercellular transport |
| GO:0032762 | 0.00978 | 125.22703 | 0 | 1 | 6 | mast cell cytokine production |
| GO:0032792 | 0.00978 | 125.22703 | 0 | 1 | 6 | negative regulation of CREB transcription factor activity |
| GO:0042695 | 0.00978 | 125.22703 | 0 | 1 | 6 | thelarche |
| GO:0043305 | 0.00978 | 125.22703 | 0 | 1 | 6 | negative regulation of mast cell degranulation |
| GO:0044531 | 0.00978 | 125.22703 | 0 | 1 | 6 | modulation of programmed cell death in other organism |
| GO:0044532 | 0.00978 | 125.22703 | 0 | 1 | 6 | modulation of apoptotic process in other organism |
| GO:0050722 | 0.00978 | 125.22703 | 0 | 1 | 6 | regulation of interleukin-1 beta biosynthetic process |
| GO:0050725 | 0.00978 | 125.22703 | 0 | 1 | 6 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0052040 | 0.00978 | 125.22703 | 0 | 1 | 6 | modulation by symbiont of host programmed cell death |
| GO:0052248 | 0.00978 | 125.22703 | 0 | 1 | 6 | modulation of programmed cell death in other organism involved in symbiotic interaction |
| GO:0052433 | 0.00978 | 125.22703 | 0 | 1 | 6 | modulation by organism of apoptotic process in other organism involved in symbiotic interaction |
| GO:0060744 | 0.00978 | 125.22703 | 0 | 1 | 6 | mammary gland branching involved in thelarche |
| GO:0060751 | 0.00978 | 125.22703 | 0 | 1 | 6 | branch elongation involved in mammary gland duct branching |
| GO:0070245 | 0.00978 | 125.22703 | 0 | 1 | 6 | positive regulation of thymocyte apoptotic process |
| GO:0071500 | 0.00978 | 125.22703 | 0 | 1 | 6 | cellular response to nitrosative stress |
| GO:0072049 | 0.00978 | 125.22703 | 0 | 1 | 6 | comma-shaped body morphogenesis |
| GO:0072298 | 0.00978 | 125.22703 | 0 | 1 | 6 | regulation of metanephric glomerulus development |
| GO:0090027 | 0.00978 | 125.22703 | 0 | 1 | 6 | negative regulation of monocyte chemotaxis |
| GO:1903026 | 0.00978 | 125.22703 | 0 | 1 | 6 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:2000015 | 0.00978 | 125.22703 | 0 | 1 | 6 | regulation of determination of dorsal identity |
| GO:2000554 | 0.00978 | 125.22703 | 0 | 1 | 6 | regulation of T-helper 1 cell cytokine production |
| GO:2000556 | 0.00978 | 125.22703 | 0 | 1 | 6 | positive regulation of T-helper 1 cell cytokine production |
| GO:2000977 | 0.00978 | 125.22703 | 0 | 1 | 6 | regulation of forebrain neuron differentiation |
| GO:0018193 | 0.00982 | 3.65401 | 2 | 6 | 1137 | peptidyl-amino acid modification |
| GO:0014909 | 0.00996 | 14.24815 | 0 | 2 | 92 | smooth muscle cell migration |
| GO:0051817 | 0.01017 | 14.09096 | 0 | 2 | 93 | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0048584 | 0.01023 | 2.83684 | 4 | 9 | 2294 | positive regulation of response to stimulus |
| GO:0009894 | 0.01044 | 4.15107 | 1 | 5 | 821 | regulation of catabolic process |
| GO:0033993 | 0.01049 | 4.14580 | 1 | 5 | 822 | response to lipid |
| GO:0070585 | 0.01059 | 13.78674 | 0 | 2 | 95 | protein localization to mitochondrion |
| GO:0043009 | 0.01060 | 4.13531 | 1 | 5 | 824 | chordate embryonic development |
| GO:0003007 | 0.01073 | 7.08458 | 0 | 3 | 280 | heart morphogenesis |
| GO:0070482 | 0.01094 | 7.03318 | 0 | 3 | 282 | response to oxygen levels |
| GO:0120036 | 0.01094 | 3.21882 | 2 | 7 | 1526 | plasma membrane bounded cell projection organization |
| GO:0009653 | 0.01095 | 2.66982 | 4 | 10 | 2744 | anatomical structure morphogenesis |
| GO:0044089 | 0.01102 | 5.02597 | 1 | 4 | 534 | positive regulation of cellular component biogenesis |
| GO:0051338 | 0.01102 | 4.09384 | 1 | 5 | 832 | regulation of transferase activity |
| GO:0002444 | 0.01102 | 13.49532 | 0 | 2 | 97 | myeloid leukocyte mediated immunity |
| GO:0070227 | 0.01124 | 13.35417 | 0 | 2 | 98 | lymphocyte apoptotic process |
| GO:0001701 | 0.01130 | 4.98744 | 1 | 4 | 538 | in utero embryonic development |
| GO:0030335 | 0.01137 | 4.97790 | 1 | 4 | 539 | positive regulation of cell migration |
| GO:0030001 | 0.01139 | 4.05821 | 1 | 5 | 839 | metal ion transport |
| GO:0001955 | 0.01141 | 104.35135 | 0 | 1 | 7 | blood vessel maturation |
| GO:0036462 | 0.01141 | 104.35135 | 0 | 1 | 7 | TRAIL-activated apoptotic signaling pathway |
| GO:0042904 | 0.01141 | 104.35135 | 0 | 1 | 7 | 9-cis-retinoic acid biosynthetic process |
| GO:0042905 | 0.01141 | 104.35135 | 0 | 1 | 7 | 9-cis-retinoic acid metabolic process |
| GO:0048387 | 0.01141 | 104.35135 | 0 | 1 | 7 | negative regulation of retinoic acid receptor signaling pathway |
| GO:0050720 | 0.01141 | 104.35135 | 0 | 1 | 7 | interleukin-1 beta biosynthetic process |
| GO:0071676 | 0.01141 | 104.35135 | 0 | 1 | 7 | negative regulation of mononuclear cell migration |
| GO:0072282 | 0.01141 | 104.35135 | 0 | 1 | 7 | metanephric nephron tubule morphogenesis |
| GO:0097646 | 0.01141 | 104.35135 | 0 | 1 | 7 | calcitonin family receptor signaling pathway |
| GO:1903753 | 0.01141 | 104.35135 | 0 | 1 | 7 | negative regulation of p38MAPK cascade |
| GO:2000271 | 0.01141 | 104.35135 | 0 | 1 | 7 | positive regulation of fibroblast apoptotic process |
| GO:0009792 | 0.01150 | 4.04814 | 1 | 5 | 841 | embryo development ending in birth or egg hatching |
| GO:0007548 | 0.01158 | 6.88331 | 0 | 3 | 288 | sex differentiation |
| GO:0048511 | 0.01190 | 6.81071 | 0 | 3 | 291 | rhythmic process |
| GO:0071214 | 0.01201 | 6.78685 | 0 | 3 | 292 | cellular response to abiotic stimulus |
| GO:0104004 | 0.01201 | 6.78685 | 0 | 3 | 292 | cellular response to environmental stimulus |
| GO:0051049 | 0.01210 | 2.92178 | 3 | 8 | 1946 | regulation of transport |
| GO:0002367 | 0.01213 | 12.81778 | 0 | 2 | 102 | cytokine production involved in immune response |
| GO:0009953 | 0.01236 | 12.69032 | 0 | 2 | 103 | dorsal/ventral pattern formation |
| GO:0035967 | 0.01236 | 12.69032 | 0 | 2 | 103 | cellular response to topologically incorrect protein |
| GO:0043933 | 0.01246 | 2.90541 | 3 | 8 | 1956 | protein-containing complex subunit organization |
| GO:0030030 | 0.01275 | 3.11757 | 3 | 7 | 1572 | cell projection organization |
| GO:0034754 | 0.01282 | 12.44283 | 0 | 2 | 105 | cellular hormone metabolic process |
| GO:1901701 | 0.01288 | 3.43312 | 2 | 6 | 1206 | cellular response to oxygen-containing compound |
| GO:0009607 | 0.01298 | 3.42710 | 2 | 6 | 1208 | response to biotic stimulus |
| GO:2000147 | 0.01301 | 4.77664 | 1 | 4 | 561 | positive regulation of cell motility |
| GO:0000185 | 0.01302 | 89.44015 | 0 | 1 | 8 | activation of MAPKKK activity |
| GO:0021861 | 0.01302 | 89.44015 | 0 | 1 | 8 | forebrain radial glial cell differentiation |
| GO:0033007 | 0.01302 | 89.44015 | 0 | 1 | 8 | negative regulation of mast cell activation involved in immune response |
| GO:0045360 | 0.01302 | 89.44015 | 0 | 1 | 8 | regulation of interleukin-1 biosynthetic process |
| GO:0045362 | 0.01302 | 89.44015 | 0 | 1 | 8 | positive regulation of interleukin-1 biosynthetic process |
| GO:0072050 | 0.01302 | 89.44015 | 0 | 1 | 8 | S-shaped body morphogenesis |
| GO:0072126 | 0.01302 | 89.44015 | 0 | 1 | 8 | positive regulation of glomerular mesangial cell proliferation |
| GO:0072239 | 0.01302 | 89.44015 | 0 | 1 | 8 | metanephric glomerulus vasculature development |
| GO:1901029 | 0.01302 | 89.44015 | 0 | 1 | 8 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GO:1901533 | 0.01302 | 89.44015 | 0 | 1 | 8 | negative regulation of hematopoietic progenitor cell differentiation |
| GO:1905076 | 0.01302 | 89.44015 | 0 | 1 | 8 | regulation of interleukin-17 secretion |
| GO:2000973 | 0.01302 | 89.44015 | 0 | 1 | 8 | regulation of pro-B cell differentiation |
| GO:0008202 | 0.01303 | 6.57929 | 0 | 3 | 301 | steroid metabolic process |
| GO:0014812 | 0.01305 | 12.32265 | 0 | 2 | 106 | muscle cell migration |
| GO:0031401 | 0.01308 | 3.42110 | 2 | 6 | 1210 | positive regulation of protein modification process |
| GO:0030316 | 0.01352 | 12.08910 | 0 | 2 | 108 | osteoclast differentiation |
| GO:0006986 | 0.01400 | 11.86420 | 0 | 2 | 110 | response to unfolded protein |
| GO:0001892 | 0.01449 | 11.64747 | 0 | 2 | 112 | embryonic placenta development |
| GO:0030334 | 0.01455 | 3.80667 | 1 | 5 | 892 | regulation of cell migration |
| GO:0050769 | 0.01455 | 4.61520 | 1 | 4 | 580 | positive regulation of neurogenesis |
| GO:0051272 | 0.01455 | 4.61520 | 1 | 4 | 580 | positive regulation of cellular component movement |
| GO:0002246 | 0.01464 | 78.25676 | 0 | 1 | 9 | wound healing involved in inflammatory response |
| GO:0002887 | 0.01464 | 78.25676 | 0 | 1 | 9 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0003310 | 0.01464 | 78.25676 | 0 | 1 | 9 | pancreatic A cell differentiation |
| GO:0030917 | 0.01464 | 78.25676 | 0 | 1 | 9 | midbrain-hindbrain boundary development |
| GO:0032471 | 0.01464 | 78.25676 | 0 | 1 | 9 | negative regulation of endoplasmic reticulum calcium ion concentration |
| GO:0042222 | 0.01464 | 78.25676 | 0 | 1 | 9 | interleukin-1 biosynthetic process |
| GO:0044849 | 0.01464 | 78.25676 | 0 | 1 | 9 | estrous cycle |
| GO:0048539 | 0.01464 | 78.25676 | 0 | 1 | 9 | bone marrow development |
| GO:0051409 | 0.01464 | 78.25676 | 0 | 1 | 9 | response to nitrosative stress |
| GO:0061009 | 0.01464 | 78.25676 | 0 | 1 | 9 | common bile duct development |
| GO:0061101 | 0.01464 | 78.25676 | 0 | 1 | 9 | neuroendocrine cell differentiation |
| GO:1903589 | 0.01464 | 78.25676 | 0 | 1 | 9 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:2000969 | 0.01464 | 78.25676 | 0 | 1 | 9 | positive regulation of AMPA receptor activity |
| GO:0032414 | 0.01498 | 11.43849 | 0 | 2 | 114 | positive regulation of ion transmembrane transporter activity |
| GO:0018108 | 0.01521 | 6.19964 | 1 | 3 | 319 | peptidyl-tyrosine phosphorylation |
| GO:0051209 | 0.01523 | 11.33677 | 0 | 2 | 115 | release of sequestered calcium ion into cytosol |
| GO:0018212 | 0.01560 | 6.14053 | 1 | 3 | 322 | peptidyl-tyrosine modification |
| GO:0040017 | 0.01566 | 4.51074 | 1 | 4 | 593 | positive regulation of locomotion |
| GO:0051283 | 0.01574 | 11.13865 | 0 | 2 | 117 | negative regulation of sequestering of calcium ion |
| GO:0010638 | 0.01584 | 4.49507 | 1 | 4 | 595 | positive regulation of organelle organization |
| GO:0043280 | 0.01625 | 10.94729 | 0 | 2 | 119 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0051282 | 0.01625 | 10.94729 | 0 | 2 | 119 | regulation of sequestering of calcium ion |
| GO:0090090 | 0.01625 | 10.94729 | 0 | 2 | 119 | negative regulation of canonical Wnt signaling pathway |
| GO:0035744 | 0.01626 | 69.55856 | 0 | 1 | 10 | T-helper 1 cell cytokine production |
| GO:0043301 | 0.01626 | 69.55856 | 0 | 1 | 10 | negative regulation of leukocyte degranulation |
| GO:0043497 | 0.01626 | 69.55856 | 0 | 1 | 10 | regulation of protein heterodimerization activity |
| GO:0043922 | 0.01626 | 69.55856 | 0 | 1 | 10 | negative regulation by host of viral transcription |
| GO:0045607 | 0.01626 | 69.55856 | 0 | 1 | 10 | regulation of inner ear auditory receptor cell differentiation |
| GO:0045631 | 0.01626 | 69.55856 | 0 | 1 | 10 | regulation of mechanoreceptor differentiation |
| GO:0046543 | 0.01626 | 69.55856 | 0 | 1 | 10 | development of secondary female sexual characteristics |
| GO:0051204 | 0.01626 | 69.55856 | 0 | 1 | 10 | protein insertion into mitochondrial membrane |
| GO:0061626 | 0.01626 | 69.55856 | 0 | 1 | 10 | pharyngeal arch artery morphogenesis |
| GO:0071305 | 0.01626 | 69.55856 | 0 | 1 | 10 | cellular response to vitamin D |
| GO:0072173 | 0.01626 | 69.55856 | 0 | 1 | 10 | metanephric tubule morphogenesis |
| GO:0072203 | 0.01626 | 69.55856 | 0 | 1 | 10 | cell proliferation involved in metanephros development |
| GO:1901724 | 0.01626 | 69.55856 | 0 | 1 | 10 | positive regulation of cell proliferation involved in kidney development |
| GO:1902947 | 0.01626 | 69.55856 | 0 | 1 | 10 | regulation of tau-protein kinase activity |
| GO:1903749 | 0.01626 | 69.55856 | 0 | 1 | 10 | positive regulation of establishment of protein localization to mitochondrion |
| GO:1905456 | 0.01626 | 69.55856 | 0 | 1 | 10 | regulation of lymphoid progenitor cell differentiation |
| GO:2000318 | 0.01626 | 69.55856 | 0 | 1 | 10 | positive regulation of T-helper 17 type immune response |
| GO:2000980 | 0.01626 | 69.55856 | 0 | 1 | 10 | regulation of inner ear receptor cell differentiation |
| GO:0071363 | 0.01646 | 4.44108 | 1 | 4 | 602 | cellular response to growth factor stimulus |
| GO:0008584 | 0.01651 | 10.85405 | 0 | 2 | 120 | male gonad development |
| GO:0051208 | 0.01651 | 10.85405 | 0 | 2 | 120 | sequestering of calcium ion |
| GO:0010975 | 0.01656 | 4.43347 | 1 | 4 | 603 | regulation of neuron projection development |
| GO:0032411 | 0.01677 | 10.76237 | 0 | 2 | 121 | positive regulation of transporter activity |
| GO:0046546 | 0.01677 | 10.76237 | 0 | 2 | 121 | development of primary male sexual characteristics |
| GO:0007423 | 0.01683 | 4.41079 | 1 | 4 | 606 | sensory organ development |
| GO:0007098 | 0.01703 | 10.67222 | 0 | 2 | 122 | centrosome cycle |
| GO:0032102 | 0.01745 | 5.87876 | 1 | 3 | 336 | negative regulation of response to external stimulus |
| GO:0051130 | 0.01747 | 3.19626 | 2 | 6 | 1290 | positive regulation of cellular component organization |
| GO:0052548 | 0.01759 | 5.86091 | 1 | 3 | 337 | regulation of endopeptidase activity |
| GO:0002138 | 0.01787 | 62.60000 | 0 | 1 | 11 | retinoic acid biosynthetic process |
| GO:0003263 | 0.01787 | 62.60000 | 0 | 1 | 11 | cardioblast proliferation |
| GO:0003266 | 0.01787 | 62.60000 | 0 | 1 | 11 | regulation of secondary heart field cardioblast proliferation |
| GO:0016102 | 0.01787 | 62.60000 | 0 | 1 | 11 | diterpenoid biosynthetic process |
| GO:0043619 | 0.01787 | 62.60000 | 0 | 1 | 11 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress |
| GO:0048262 | 0.01787 | 62.60000 | 0 | 1 | 11 | determination of dorsal/ventral asymmetry |
| GO:0048263 | 0.01787 | 62.60000 | 0 | 1 | 11 | determination of dorsal identity |
| GO:0048563 | 0.01787 | 62.60000 | 0 | 1 | 11 | post-embryonic animal organ morphogenesis |
| GO:0060600 | 0.01787 | 62.60000 | 0 | 1 | 11 | dichotomous subdivision of an epithelial terminal unit |
| GO:0061309 | 0.01787 | 62.60000 | 0 | 1 | 11 | cardiac neural crest cell development involved in outflow tract morphogenesis |
| GO:0090281 | 0.01787 | 62.60000 | 0 | 1 | 11 | negative regulation of calcium ion import |
| GO:0097084 | 0.01787 | 62.60000 | 0 | 1 | 11 | vascular smooth muscle cell development |
| GO:0097421 | 0.01787 | 62.60000 | 0 | 1 | 11 | liver regeneration |
| GO:1901030 | 0.01787 | 62.60000 | 0 | 1 | 11 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GO:0031623 | 0.01809 | 10.32616 | 0 | 2 | 126 | receptor internalization |
| GO:1901342 | 0.01814 | 5.79053 | 1 | 3 | 341 | regulation of vasculature development |
| GO:0006810 | 0.01888 | 2.22788 | 7 | 13 | 4398 | transport |
| GO:0001936 | 0.01891 | 10.08093 | 0 | 2 | 129 | regulation of endothelial cell proliferation |
| GO:0045995 | 0.01891 | 10.08093 | 0 | 2 | 129 | regulation of embryonic development |
| GO:0007507 | 0.01893 | 4.25113 | 1 | 4 | 628 | heart development |
| GO:0031023 | 0.01919 | 10.00174 | 0 | 2 | 130 | microtubule organizing center organization |
| GO:0060341 | 0.01924 | 3.53254 | 2 | 5 | 958 | regulation of cellular localization |
| GO:0045787 | 0.01928 | 5.65467 | 1 | 3 | 349 | positive regulation of cell cycle |
| GO:0003264 | 0.01948 | 56.90663 | 0 | 1 | 12 | regulation of cardioblast proliferation |
| GO:0033004 | 0.01948 | 56.90663 | 0 | 1 | 12 | negative regulation of mast cell activation |
| GO:0045080 | 0.01948 | 56.90663 | 0 | 1 | 12 | positive regulation of chemokine biosynthetic process |
| GO:0060213 | 0.01948 | 56.90663 | 0 | 1 | 12 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0071281 | 0.01948 | 56.90663 | 0 | 1 | 12 | cellular response to iron ion |
| GO:0072124 | 0.01948 | 56.90663 | 0 | 1 | 12 | regulation of glomerular mesangial cell proliferation |
| GO:0072615 | 0.01948 | 56.90663 | 0 | 1 | 12 | interleukin-17 secretion |
| GO:0097201 | 0.01948 | 56.90663 | 0 | 1 | 12 | negative regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0071887 | 0.01974 | 9.84701 | 0 | 2 | 132 | leukocyte apoptotic process |
| GO:0051128 | 0.01994 | 2.51088 | 4 | 9 | 2558 | regulation of cellular component organization |
| GO:0009855 | 0.02002 | 9.77142 | 0 | 2 | 133 | determination of bilateral symmetry |
| GO:0035966 | 0.02002 | 9.77142 | 0 | 2 | 133 | response to topologically incorrect protein |
| GO:0009799 | 0.02031 | 9.69697 | 0 | 2 | 134 | specification of symmetry |
| GO:0045598 | 0.02059 | 9.62364 | 0 | 2 | 135 | regulation of fat cell differentiation |
| GO:0050678 | 0.02061 | 5.50913 | 1 | 3 | 358 | regulation of epithelial cell proliferation |
| GO:0097553 | 0.02088 | 9.55141 | 0 | 2 | 136 | calcium ion transmembrane import into cytosol |
| GO:2001056 | 0.02088 | 9.55141 | 0 | 2 | 136 | positive regulation of cysteine-type endopeptidase activity |
| GO:0001542 | 0.02108 | 52.16216 | 0 | 1 | 13 | ovulation from ovarian follicle |
| GO:0002328 | 0.02108 | 52.16216 | 0 | 1 | 13 | pro-B cell differentiation |
| GO:0019054 | 0.02108 | 52.16216 | 0 | 1 | 13 | modulation by virus of host process |
| GO:0031953 | 0.02108 | 52.16216 | 0 | 1 | 13 | negative regulation of protein autophosphorylation |
| GO:0033280 | 0.02108 | 52.16216 | 0 | 1 | 13 | response to vitamin D |
| GO:0045136 | 0.02108 | 52.16216 | 0 | 1 | 13 | development of secondary sexual characteristics |
| GO:0045820 | 0.02108 | 52.16216 | 0 | 1 | 13 | negative regulation of glycolytic process |
| GO:0061418 | 0.02108 | 52.16216 | 0 | 1 | 13 | regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| GO:0071295 | 0.02108 | 52.16216 | 0 | 1 | 13 | cellular response to vitamin |
| GO:0072110 | 0.02108 | 52.16216 | 0 | 1 | 13 | glomerular mesangial cell proliferation |
| GO:0072216 | 0.02108 | 52.16216 | 0 | 1 | 13 | positive regulation of metanephros development |
| GO:0090193 | 0.02108 | 52.16216 | 0 | 1 | 13 | positive regulation of glomerulus development |
| GO:0090594 | 0.02108 | 52.16216 | 0 | 1 | 13 | inflammatory response to wounding |
| GO:1902715 | 0.02108 | 52.16216 | 0 | 1 | 13 | positive regulation of interferon-gamma secretion |
| GO:1903025 | 0.02108 | 52.16216 | 0 | 1 | 13 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1903587 | 0.02108 | 52.16216 | 0 | 1 | 13 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0044283 | 0.02118 | 4.10235 | 1 | 4 | 650 | small molecule biosynthetic process |
| GO:0051962 | 0.02129 | 4.09583 | 1 | 4 | 651 | positive regulation of nervous system development |
| GO:0007050 | 0.02145 | 9.41013 | 0 | 2 | 138 | cell cycle arrest |
| GO:0030216 | 0.02175 | 9.34104 | 0 | 2 | 139 | keratinocyte differentiation |
| GO:0001934 | 0.02176 | 3.41648 | 2 | 5 | 989 | positive regulation of protein phosphorylation |
| GO:0016311 | 0.02183 | 5.38583 | 1 | 3 | 366 | dephosphorylation |
| GO:0010720 | 0.02215 | 4.04436 | 1 | 4 | 659 | positive regulation of cell development |
| GO:0045321 | 0.02218 | 3.39844 | 2 | 5 | 994 | leukocyte activation |
| GO:0003334 | 0.02269 | 48.14761 | 0 | 1 | 14 | keratinocyte development |
| GO:0021903 | 0.02269 | 48.14761 | 0 | 1 | 14 | rostrocaudal neural tube patterning |
| GO:0021984 | 0.02269 | 48.14761 | 0 | 1 | 14 | adenohypophysis development |
| GO:0030812 | 0.02269 | 48.14761 | 0 | 1 | 14 | negative regulation of nucleotide catabolic process |
| GO:0048505 | 0.02269 | 48.14761 | 0 | 1 | 14 | regulation of timing of cell differentiation |
| GO:0048711 | 0.02269 | 48.14761 | 0 | 1 | 14 | positive regulation of astrocyte differentiation |
| GO:0051198 | 0.02269 | 48.14761 | 0 | 1 | 14 | negative regulation of coenzyme metabolic process |
| GO:0051782 | 0.02269 | 48.14761 | 0 | 1 | 14 | negative regulation of cell division |
| GO:0060019 | 0.02269 | 48.14761 | 0 | 1 | 14 | radial glial cell differentiation |
| GO:0060211 | 0.02269 | 48.14761 | 0 | 1 | 14 | regulation of nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0061308 | 0.02269 | 48.14761 | 0 | 1 | 14 | cardiac neural crest cell development involved in heart development |
| GO:0071850 | 0.02269 | 48.14761 | 0 | 1 | 14 | mitotic cell cycle arrest |
| GO:0072224 | 0.02269 | 48.14761 | 0 | 1 | 14 | metanephric glomerulus development |
| GO:0001935 | 0.02293 | 9.07447 | 0 | 2 | 143 | endothelial cell proliferation |
| GO:0009267 | 0.02293 | 9.07447 | 0 | 2 | 143 | cellular response to starvation |
| GO:0010634 | 0.02293 | 9.07447 | 0 | 2 | 143 | positive regulation of epithelial cell migration |
| GO:0072594 | 0.02309 | 5.26785 | 1 | 3 | 374 | establishment of protein localization to organelle |
| GO:0007613 | 0.02323 | 9.01017 | 0 | 2 | 144 | memory |
| GO:0031099 | 0.02353 | 8.94678 | 0 | 2 | 145 | regeneration |
| GO:0072006 | 0.02383 | 8.88426 | 0 | 2 | 146 | nephron development |
| GO:0060562 | 0.02406 | 5.18264 | 1 | 3 | 380 | epithelial tube morphogenesis |
| GO:0051234 | 0.02412 | 2.14286 | 7 | 13 | 4538 | establishment of localization |
| GO:0030856 | 0.02413 | 8.82261 | 0 | 2 | 147 | regulation of epithelial cell differentiation |
| GO:0016114 | 0.02429 | 44.70656 | 0 | 1 | 15 | terpenoid biosynthetic process |
| GO:0042033 | 0.02429 | 44.70656 | 0 | 1 | 15 | chemokine biosynthetic process |
| GO:0045073 | 0.02429 | 44.70656 | 0 | 1 | 15 | regulation of chemokine biosynthetic process |
| GO:0045605 | 0.02429 | 44.70656 | 0 | 1 | 15 | negative regulation of epidermal cell differentiation |
| GO:0048070 | 0.02429 | 44.70656 | 0 | 1 | 15 | regulation of developmental pigmentation |
| GO:0048385 | 0.02429 | 44.70656 | 0 | 1 | 15 | regulation of retinoic acid receptor signaling pathway |
| GO:0051712 | 0.02429 | 44.70656 | 0 | 1 | 15 | positive regulation of killing of cells of other organism |
| GO:0060347 | 0.02429 | 44.70656 | 0 | 1 | 15 | heart trabecula formation |
| GO:0061029 | 0.02429 | 44.70656 | 0 | 1 | 15 | eyelid development in camera-type eye |
| GO:0061307 | 0.02429 | 44.70656 | 0 | 1 | 15 | cardiac neural crest cell differentiation involved in heart development |
| GO:0070234 | 0.02429 | 44.70656 | 0 | 1 | 15 | positive regulation of T cell apoptotic process |
| GO:0071243 | 0.02429 | 44.70656 | 0 | 1 | 15 | cellular response to arsenic-containing substance |
| GO:1902043 | 0.02429 | 44.70656 | 0 | 1 | 15 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0001817 | 0.02440 | 3.92105 | 1 | 4 | 679 | regulation of cytokine production |
| GO:0002700 | 0.02444 | 8.76180 | 0 | 2 | 148 | regulation of production of molecular mediator of immune response |
| GO:0003206 | 0.02444 | 8.76180 | 0 | 2 | 148 | cardiac chamber morphogenesis |
| GO:0050728 | 0.02475 | 8.70181 | 0 | 2 | 149 | negative regulation of inflammatory response |
| GO:0034614 | 0.02505 | 8.64264 | 0 | 2 | 150 | cellular response to reactive oxygen species |
| GO:0030178 | 0.02536 | 8.58427 | 0 | 2 | 151 | negative regulation of Wnt signaling pathway |
| GO:0046661 | 0.02568 | 8.52667 | 0 | 2 | 152 | male sex differentiation |
| GO:0098655 | 0.02570 | 3.85629 | 1 | 4 | 690 | cation transmembrane transport |
| GO:0006954 | 0.02582 | 3.85050 | 1 | 4 | 691 | inflammatory response |
| GO:0002689 | 0.02588 | 41.72432 | 0 | 1 | 16 | negative regulation of leukocyte chemotaxis |
| GO:0040034 | 0.02588 | 41.72432 | 0 | 1 | 16 | regulation of development, heterochronic |
| GO:0043923 | 0.02588 | 41.72432 | 0 | 1 | 16 | positive regulation by host of viral transcription |
| GO:0044068 | 0.02588 | 41.72432 | 0 | 1 | 16 | modulation by symbiont of host cellular process |
| GO:0048715 | 0.02588 | 41.72432 | 0 | 1 | 16 | negative regulation of oligodendrocyte differentiation |
| GO:0051709 | 0.02588 | 41.72432 | 0 | 1 | 16 | regulation of killing of cells of other organism |
| GO:0070262 | 0.02588 | 41.72432 | 0 | 1 | 16 | peptidyl-serine dephosphorylation |
| GO:0072109 | 0.02588 | 41.72432 | 0 | 1 | 16 | glomerular mesangium development |
| GO:1901722 | 0.02588 | 41.72432 | 0 | 1 | 16 | regulation of cell proliferation involved in kidney development |
| GO:2000651 | 0.02588 | 41.72432 | 0 | 1 | 16 | positive regulation of sodium ion transmembrane transporter activity |
| GO:0010950 | 0.02599 | 8.46983 | 0 | 2 | 153 | positive regulation of endopeptidase activity |
| GO:0009725 | 0.02654 | 3.81614 | 1 | 4 | 697 | response to hormone |
| GO:0042327 | 0.02664 | 3.23086 | 2 | 5 | 1043 | positive regulation of phosphorylation |
| GO:0051090 | 0.02676 | 4.96816 | 1 | 3 | 396 | regulation of DNA-binding transcription factor activity |
| GO:0060402 | 0.02726 | 8.24982 | 0 | 2 | 157 | calcium ion transport into cytosol |
| GO:0009886 | 0.02748 | 39.11486 | 0 | 1 | 17 | post-embryonic animal morphogenesis |
| GO:0010454 | 0.02748 | 39.11486 | 0 | 1 | 17 | negative regulation of cell fate commitment |
| GO:0032740 | 0.02748 | 39.11486 | 0 | 1 | 17 | positive regulation of interleukin-17 production |
| GO:0038092 | 0.02748 | 39.11486 | 0 | 1 | 17 | nodal signaling pathway |
| GO:0050755 | 0.02748 | 39.11486 | 0 | 1 | 17 | chemokine metabolic process |
| GO:0060253 | 0.02748 | 39.11486 | 0 | 1 | 17 | negative regulation of glial cell proliferation |
| GO:0070243 | 0.02748 | 39.11486 | 0 | 1 | 17 | regulation of thymocyte apoptotic process |
| GO:0072234 | 0.02748 | 39.11486 | 0 | 1 | 17 | metanephric nephron tubule development |
| GO:0090192 | 0.02748 | 39.11486 | 0 | 1 | 17 | regulation of glomerulus development |
| GO:1900452 | 0.02748 | 39.11486 | 0 | 1 | 17 | regulation of long-term synaptic depression |
| GO:1902713 | 0.02748 | 39.11486 | 0 | 1 | 17 | regulation of interferon-gamma secretion |
| GO:2001170 | 0.02748 | 39.11486 | 0 | 1 | 17 | negative regulation of ATP biosynthetic process |
| GO:1903707 | 0.02758 | 8.19658 | 0 | 2 | 158 | negative regulation of hemopoiesis |
| GO:0035821 | 0.02823 | 8.09212 | 0 | 2 | 160 | modification of morphology or physiology of other organism |
| GO:2001236 | 0.02856 | 8.04088 | 0 | 2 | 161 | regulation of extrinsic apoptotic signaling pathway |
| GO:0010952 | 0.02888 | 7.99028 | 0 | 2 | 162 | positive regulation of peptidase activity |
| GO:0006700 | 0.02907 | 36.81240 | 0 | 1 | 18 | C21-steroid hormone biosynthetic process |
| GO:0010566 | 0.02907 | 36.81240 | 0 | 1 | 18 | regulation of ketone biosynthetic process |
| GO:0021542 | 0.02907 | 36.81240 | 0 | 1 | 18 | dentate gyrus development |
| GO:0021783 | 0.02907 | 36.81240 | 0 | 1 | 18 | preganglionic parasympathetic fiber development |
| GO:0030809 | 0.02907 | 36.81240 | 0 | 1 | 18 | negative regulation of nucleotide biosynthetic process |
| GO:0060712 | 0.02907 | 36.81240 | 0 | 1 | 18 | spongiotrophoblast layer development |
| GO:1900153 | 0.02907 | 36.81240 | 0 | 1 | 18 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:1900372 | 0.02907 | 36.81240 | 0 | 1 | 18 | negative regulation of purine nucleotide biosynthetic process |
| GO:1904706 | 0.02907 | 36.81240 | 0 | 1 | 18 | negative regulation of vascular smooth muscle cell proliferation |
| GO:0030879 | 0.02921 | 7.94030 | 0 | 2 | 163 | mammary gland development |
| GO:1904064 | 0.02921 | 7.94030 | 0 | 2 | 163 | positive regulation of cation transmembrane transport |
| GO:0051093 | 0.02933 | 3.14511 | 2 | 5 | 1070 | negative regulation of developmental process |
| GO:0052547 | 0.02943 | 4.78235 | 1 | 3 | 411 | regulation of peptidase activity |
| GO:0007179 | 0.02987 | 7.84219 | 0 | 2 | 165 | transforming growth factor beta receptor signaling pathway |
| GO:0045931 | 0.03021 | 7.79404 | 0 | 2 | 166 | positive regulation of mitotic cell cycle |
| GO:0007610 | 0.03049 | 3.64771 | 1 | 4 | 728 | behavior |
| GO:0002043 | 0.03066 | 34.76577 | 0 | 1 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0002726 | 0.03066 | 34.76577 | 0 | 1 | 19 | positive regulation of T cell cytokine production |
| GO:0008209 | 0.03066 | 34.76577 | 0 | 1 | 19 | androgen metabolic process |
| GO:0010528 | 0.03066 | 34.76577 | 0 | 1 | 19 | regulation of transposition |
| GO:0010529 | 0.03066 | 34.76577 | 0 | 1 | 19 | negative regulation of transposition |
| GO:0042789 | 0.03066 | 34.76577 | 0 | 1 | 19 | mRNA transcription by RNA polymerase II |
| GO:0046886 | 0.03066 | 34.76577 | 0 | 1 | 19 | positive regulation of hormone biosynthetic process |
| GO:0051818 | 0.03066 | 34.76577 | 0 | 1 | 19 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0051883 | 0.03066 | 34.76577 | 0 | 1 | 19 | killing of cells in other organism involved in symbiotic interaction |
| GO:1900451 | 0.03066 | 34.76577 | 0 | 1 | 19 | positive regulation of glutamate receptor signaling pathway |
| GO:1904754 | 0.03066 | 34.76577 | 0 | 1 | 19 | positive regulation of vascular associated smooth muscle cell migration |
| GO:2000251 | 0.03066 | 34.76577 | 0 | 1 | 19 | positive regulation of actin cytoskeleton reorganization |
| GO:2000269 | 0.03066 | 34.76577 | 0 | 1 | 19 | regulation of fibroblast apoptotic process |
| GO:0030509 | 0.03088 | 7.69946 | 0 | 2 | 168 | BMP signaling pathway |
| GO:0022414 | 0.03099 | 2.77820 | 2 | 6 | 1471 | reproductive process |
| GO:0000003 | 0.03108 | 2.77618 | 2 | 6 | 1472 | reproduction |
| GO:0002697 | 0.03110 | 4.67729 | 1 | 3 | 420 | regulation of immune effector process |
| GO:0009887 | 0.03143 | 3.08435 | 2 | 5 | 1090 | animal organ morphogenesis |
| GO:0001890 | 0.03156 | 7.60714 | 0 | 2 | 170 | placenta development |
| GO:0060401 | 0.03156 | 7.60714 | 0 | 2 | 170 | cytosolic calcium ion transport |
| GO:0097237 | 0.03156 | 7.60714 | 0 | 2 | 170 | cellular response to toxic substance |
| GO:0007612 | 0.03190 | 7.56180 | 0 | 2 | 171 | learning |
| GO:0010039 | 0.03225 | 32.93457 | 0 | 1 | 20 | response to iron ion |
| GO:0045986 | 0.03225 | 32.93457 | 0 | 1 | 20 | negative regulation of smooth muscle contraction |
| GO:0050434 | 0.03225 | 32.93457 | 0 | 1 | 20 | positive regulation of viral transcription |
| GO:0051195 | 0.03225 | 32.93457 | 0 | 1 | 20 | negative regulation of cofactor metabolic process |
| GO:0061323 | 0.03225 | 32.93457 | 0 | 1 | 20 | cell proliferation involved in heart morphogenesis |
| GO:0070498 | 0.03225 | 32.93457 | 0 | 1 | 20 | interleukin-1-mediated signaling pathway |
| GO:0072243 | 0.03225 | 32.93457 | 0 | 1 | 20 | metanephric nephron epithelium development |
| GO:1900151 | 0.03225 | 32.93457 | 0 | 1 | 20 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| GO:2000136 | 0.03225 | 32.93457 | 0 | 1 | 20 | regulation of cell proliferation involved in heart morphogenesis |
| GO:2000678 | 0.03225 | 32.93457 | 0 | 1 | 20 | negative regulation of transcription regulatory region DNA binding |
| GO:0001775 | 0.03230 | 3.06066 | 2 | 5 | 1098 | cell activation |
| GO:0051649 | 0.03300 | 2.52953 | 3 | 7 | 1906 | establishment of localization in cell |
| GO:0043902 | 0.03328 | 7.38568 | 0 | 2 | 175 | positive regulation of multi-organism process |
| GO:0002262 | 0.03362 | 7.34291 | 0 | 2 | 176 | myeloid cell homeostasis |
| GO:0009612 | 0.03362 | 7.34291 | 0 | 2 | 176 | response to mechanical stimulus |
| GO:0035148 | 0.03362 | 7.34291 | 0 | 2 | 176 | tube formation |
| GO:0007095 | 0.03384 | 31.28649 | 0 | 1 | 21 | mitotic G2 DNA damage checkpoint |
| GO:0044346 | 0.03384 | 31.28649 | 0 | 1 | 21 | fibroblast apoptotic process |
| GO:0045475 | 0.03384 | 31.28649 | 0 | 1 | 21 | locomotor rhythm |
| GO:0048486 | 0.03384 | 31.28649 | 0 | 1 | 21 | parasympathetic nervous system development |
| GO:0048569 | 0.03384 | 31.28649 | 0 | 1 | 21 | post-embryonic animal organ development |
| GO:0070230 | 0.03384 | 31.28649 | 0 | 1 | 21 | positive regulation of lymphocyte apoptotic process |
| GO:0072170 | 0.03384 | 31.28649 | 0 | 1 | 21 | metanephric tubule development |
| GO:0090050 | 0.03384 | 31.28649 | 0 | 1 | 21 | positive regulation of cell migration involved in sprouting angiogenesis |
| GO:0010562 | 0.03385 | 3.02004 | 2 | 5 | 1112 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.03385 | 3.02004 | 2 | 5 | 1112 | positive regulation of phosphate metabolic process |
| GO:0001816 | 0.03419 | 3.51234 | 1 | 4 | 755 | cytokine production |
| GO:0032386 | 0.03459 | 4.48020 | 1 | 3 | 438 | regulation of intracellular transport |
| GO:0001659 | 0.03468 | 7.21751 | 0 | 2 | 179 | temperature homeostasis |
| GO:0034767 | 0.03468 | 7.21751 | 0 | 2 | 179 | positive regulation of ion transmembrane transport |
| GO:0071772 | 0.03468 | 7.21751 | 0 | 2 | 179 | response to BMP |
| GO:0071773 | 0.03468 | 7.21751 | 0 | 2 | 179 | cellular response to BMP stimulus |
| GO:0051052 | 0.03499 | 4.45930 | 1 | 3 | 440 | regulation of DNA metabolic process |
| GO:0032196 | 0.03542 | 29.79537 | 0 | 1 | 22 | transposition |
| GO:0032897 | 0.03542 | 29.79537 | 0 | 1 | 22 | negative regulation of viral transcription |
| GO:0043153 | 0.03542 | 29.79537 | 0 | 1 | 22 | entrainment of circadian clock by photoperiod |
| GO:0045683 | 0.03542 | 29.79537 | 0 | 1 | 22 | negative regulation of epidermis development |
| GO:0060602 | 0.03542 | 29.79537 | 0 | 1 | 22 | branch elongation of an epithelium |
| GO:0060749 | 0.03542 | 29.79537 | 0 | 1 | 22 | mammary gland alveolus development |
| GO:0061377 | 0.03542 | 29.79537 | 0 | 1 | 22 | mammary gland lobule development |
| GO:0072111 | 0.03542 | 29.79537 | 0 | 1 | 22 | cell proliferation involved in kidney development |
| GO:0072215 | 0.03542 | 29.79537 | 0 | 1 | 22 | regulation of metanephros development |
| GO:0072273 | 0.03542 | 29.79537 | 0 | 1 | 22 | metanephric nephron morphogenesis |
| GO:1902307 | 0.03542 | 29.79537 | 0 | 1 | 22 | positive regulation of sodium ion transmembrane transport |
| GO:1904469 | 0.03542 | 29.79537 | 0 | 1 | 22 | positive regulation of tumor necrosis factor secretion |
| GO:0120035 | 0.03666 | 3.43199 | 1 | 4 | 772 | regulation of plasma membrane bounded cell projection organization |
| GO:0001819 | 0.03681 | 4.36758 | 1 | 3 | 449 | positive regulation of cytokine production |
| GO:0002320 | 0.03700 | 28.43980 | 0 | 1 | 23 | lymphoid progenitor cell differentiation |
| GO:0002719 | 0.03700 | 28.43980 | 0 | 1 | 23 | negative regulation of cytokine production involved in immune response |
| GO:0002827 | 0.03700 | 28.43980 | 0 | 1 | 23 | positive regulation of T-helper 1 type immune response |
| GO:0009648 | 0.03700 | 28.43980 | 0 | 1 | 23 | photoperiodism |
| GO:0035743 | 0.03700 | 28.43980 | 0 | 1 | 23 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0099149 | 0.03700 | 28.43980 | 0 | 1 | 23 | regulation of postsynaptic neurotransmitter receptor internalization |
| GO:1903306 | 0.03700 | 28.43980 | 0 | 1 | 23 | negative regulation of regulated secretory pathway |
| GO:2000316 | 0.03700 | 28.43980 | 0 | 1 | 23 | regulation of T-helper 17 type immune response |
| GO:1903305 | 0.03719 | 6.94082 | 0 | 2 | 186 | regulation of regulated secretory pathway |
| GO:0031344 | 0.03801 | 3.39087 | 1 | 4 | 781 | regulation of cell projection organization |
| GO:0019048 | 0.03858 | 27.20212 | 0 | 1 | 24 | modulation by virus of host morphology or physiology |
| GO:0030728 | 0.03858 | 27.20212 | 0 | 1 | 24 | ovulation |
| GO:0032352 | 0.03858 | 27.20212 | 0 | 1 | 24 | positive regulation of hormone metabolic process |
| GO:0033233 | 0.03858 | 27.20212 | 0 | 1 | 24 | regulation of protein sumoylation |
| GO:0043921 | 0.03858 | 27.20212 | 0 | 1 | 24 | modulation by host of viral transcription |
| GO:0046685 | 0.03858 | 27.20212 | 0 | 1 | 24 | response to arsenic-containing substance |
| GO:0052312 | 0.03858 | 27.20212 | 0 | 1 | 24 | modulation of transcription in other organism involved in symbiotic interaction |
| GO:0052472 | 0.03858 | 27.20212 | 0 | 1 | 24 | modulation by host of symbiont transcription |
| GO:0072207 | 0.03858 | 27.20212 | 0 | 1 | 24 | metanephric epithelium development |
| GO:0072643 | 0.03858 | 27.20212 | 0 | 1 | 24 | interferon-gamma secretion |
| GO:0097150 | 0.03858 | 27.20212 | 0 | 1 | 24 | neuronal stem cell population maintenance |
| GO:0021915 | 0.03902 | 6.75573 | 0 | 2 | 191 | neural tube development |
| GO:0045666 | 0.03933 | 4.25090 | 1 | 3 | 461 | positive regulation of neuron differentiation |
| GO:0044270 | 0.03975 | 4.23205 | 1 | 3 | 463 | cellular nitrogen compound catabolic process |
| GO:0000289 | 0.04016 | 26.06757 | 0 | 1 | 25 | nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0009649 | 0.04016 | 26.06757 | 0 | 1 | 25 | entrainment of circadian clock |
| GO:0031100 | 0.04016 | 26.06757 | 0 | 1 | 25 | animal organ regeneration |
| GO:0032469 | 0.04016 | 26.06757 | 0 | 1 | 25 | endoplasmic reticulum calcium ion homeostasis |
| GO:0042573 | 0.04016 | 26.06757 | 0 | 1 | 25 | retinoic acid metabolic process |
| GO:0051205 | 0.04016 | 26.06757 | 0 | 1 | 25 | protein insertion into membrane |
| GO:1903747 | 0.04016 | 26.06757 | 0 | 1 | 25 | regulation of establishment of protein localization to mitochondrion |
| GO:1904738 | 0.04016 | 26.06757 | 0 | 1 | 25 | vascular associated smooth muscle cell migration |
| GO:1904752 | 0.04016 | 26.06757 | 0 | 1 | 25 | regulation of vascular associated smooth muscle cell migration |
| GO:2000737 | 0.04016 | 26.06757 | 0 | 1 | 25 | negative regulation of stem cell differentiation |
| GO:0006811 | 0.04019 | 2.59938 | 3 | 6 | 1565 | ion transport |
| GO:0003205 | 0.04051 | 6.61457 | 0 | 2 | 195 | cardiac chamber development |
| GO:0042180 | 0.04051 | 6.61457 | 0 | 2 | 195 | cellular ketone metabolic process |
| GO:0050731 | 0.04051 | 6.61457 | 0 | 2 | 195 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0045596 | 0.04078 | 3.31143 | 1 | 4 | 799 | negative regulation of cell differentiation |
| GO:0046700 | 0.04105 | 4.17646 | 1 | 3 | 469 | heterocycle catabolic process |
| GO:0009743 | 0.04164 | 6.51247 | 0 | 2 | 198 | response to carbohydrate |
| GO:0043903 | 0.04164 | 6.51247 | 0 | 2 | 198 | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0009299 | 0.04173 | 25.02378 | 0 | 1 | 26 | mRNA transcription |
| GO:0060716 | 0.04173 | 25.02378 | 0 | 1 | 26 | labyrinthine layer blood vessel development |
| GO:0090025 | 0.04173 | 25.02378 | 0 | 1 | 26 | regulation of monocyte chemotaxis |
| GO:1903579 | 0.04173 | 25.02378 | 0 | 1 | 26 | negative regulation of ATP metabolic process |
| GO:2000311 | 0.04173 | 25.02378 | 0 | 1 | 26 | regulation of AMPA receptor activity |
| GO:0050679 | 0.04202 | 6.47913 | 0 | 2 | 199 | positive regulation of epithelial cell proliferation |
| GO:0008217 | 0.04240 | 6.44613 | 0 | 2 | 200 | regulation of blood pressure |
| GO:2000377 | 0.04240 | 6.44613 | 0 | 2 | 200 | regulation of reactive oxygen species metabolic process |
| GO:0043281 | 0.04279 | 6.41346 | 0 | 2 | 201 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0002347 | 0.04330 | 24.06029 | 0 | 1 | 27 | response to tumor cell |
| GO:0003085 | 0.04330 | 24.06029 | 0 | 1 | 27 | negative regulation of systemic arterial blood pressure |
| GO:0003338 | 0.04330 | 24.06029 | 0 | 1 | 27 | metanephros morphogenesis |
| GO:0008340 | 0.04330 | 24.06029 | 0 | 1 | 27 | determination of adult lifespan |
| GO:0060343 | 0.04330 | 24.06029 | 0 | 1 | 27 | trabecula formation |
| GO:1900543 | 0.04330 | 24.06029 | 0 | 1 | 27 | negative regulation of purine nucleotide metabolic process |
| GO:1901532 | 0.04330 | 24.06029 | 0 | 1 | 27 | regulation of hematopoietic progenitor cell differentiation |
| GO:0007160 | 0.04394 | 6.31738 | 0 | 2 | 204 | cell-matrix adhesion |
| GO:0071560 | 0.04394 | 6.31738 | 0 | 2 | 204 | cellular response to transforming growth factor beta stimulus |
| GO:1904018 | 0.04394 | 6.31738 | 0 | 2 | 204 | positive regulation of vasculature development |
| GO:0019439 | 0.04415 | 4.05214 | 1 | 3 | 483 | aromatic compound catabolic process |
| GO:0043112 | 0.04433 | 6.28599 | 0 | 2 | 205 | receptor metabolic process |
| GO:0044003 | 0.04487 | 23.16817 | 0 | 1 | 28 | modification by symbiont of host morphology or physiology |
| GO:0045671 | 0.04487 | 23.16817 | 0 | 1 | 28 | negative regulation of osteoclast differentiation |
| GO:0045980 | 0.04487 | 23.16817 | 0 | 1 | 28 | negative regulation of nucleotide metabolic process |
| GO:0060037 | 0.04487 | 23.16817 | 0 | 1 | 28 | pharyngeal system development |
| GO:0060444 | 0.04487 | 23.16817 | 0 | 1 | 28 | branching involved in mammary gland duct morphogenesis |
| GO:1900745 | 0.04487 | 23.16817 | 0 | 1 | 28 | positive regulation of p38MAPK cascade |
| GO:2000178 | 0.04487 | 23.16817 | 0 | 1 | 28 | negative regulation of neural precursor cell proliferation |
| GO:0007623 | 0.04550 | 6.19364 | 0 | 2 | 208 | circadian rhythm |
| GO:0071559 | 0.04550 | 6.19364 | 0 | 2 | 208 | response to transforming growth factor beta |
| GO:0031116 | 0.04643 | 22.33977 | 0 | 1 | 29 | positive regulation of microtubule polymerization |
| GO:0033137 | 0.04643 | 22.33977 | 0 | 1 | 29 | negative regulation of peptidyl-serine phosphorylation |
| GO:0033273 | 0.04643 | 22.33977 | 0 | 1 | 29 | response to vitamin |
| GO:0060914 | 0.04643 | 22.33977 | 0 | 1 | 29 | heart formation |
| GO:0071480 | 0.04643 | 22.33977 | 0 | 1 | 29 | cellular response to gamma radiation |
| GO:1902042 | 0.04643 | 22.33977 | 0 | 1 | 29 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0009611 | 0.04691 | 3.95122 | 1 | 3 | 495 | response to wounding |
| GO:0002724 | 0.04800 | 21.56850 | 0 | 1 | 30 | regulation of T cell cytokine production |
| GO:0002825 | 0.04800 | 21.56850 | 0 | 1 | 30 | regulation of T-helper 1 type immune response |
| GO:0016242 | 0.04800 | 21.56850 | 0 | 1 | 30 | negative regulation of macroautophagy |
| GO:0035066 | 0.04800 | 21.56850 | 0 | 1 | 30 | positive regulation of histone acetylation |
| GO:0042168 | 0.04800 | 21.56850 | 0 | 1 | 30 | heme metabolic process |
| GO:0048384 | 0.04800 | 21.56850 | 0 | 1 | 30 | retinoic acid receptor signaling pathway |
| GO:0061082 | 0.04800 | 21.56850 | 0 | 1 | 30 | myeloid leukocyte cytokine production |
| GO:2000778 | 0.04800 | 21.56850 | 0 | 1 | 30 | positive regulation of interleukin-6 secretion |
| GO:0009790 | 0.04896 | 2.71220 | 2 | 5 | 1231 | embryo development |
| GO:0042445 | 0.04949 | 5.90432 | 0 | 2 | 218 | hormone metabolic process |
| GO:0008299 | 0.04956 | 20.84865 | 0 | 1 | 31 | isoprenoid biosynthetic process |
| GO:0044818 | 0.04956 | 20.84865 | 0 | 1 | 31 | mitotic G2/M transition checkpoint |
| GO:0045662 | 0.04956 | 20.84865 | 0 | 1 | 31 | negative regulation of myoblast differentiation |
| GO:0045920 | 0.04956 | 20.84865 | 0 | 1 | 31 | negative regulation of exocytosis |
| GO:0045932 | 0.04956 | 20.84865 | 0 | 1 | 31 | negative regulation of muscle contraction |
| GO:0090162 | 0.04956 | 20.84865 | 0 | 1 | 31 | establishment of epithelial cell polarity |
| GO:0098884 | 0.04956 | 20.84865 | 0 | 1 | 31 | postsynaptic neurotransmitter receptor internalization |
| GO:0140239 | 0.04956 | 20.84865 | 0 | 1 | 31 | postsynaptic endocytosis |
| GO:2000144 | 0.04956 | 20.84865 | 0 | 1 | 31 | positive regulation of DNA-templated transcription, initiation |
| GO:0002443 | 0.04975 | 3.85510 | 1 | 3 | 507 | leukocyte mediated immunity |